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Abstract 
 
Development of an LC-MS/MS method for the analysis of Saccharomyces 
cerevisiae lipidome to determine the mechanism through which plant extract 21 
delays aging by remodeling lipid composition 
 
Karamat Mohammad 
 
Aging is a multifactorial process that occurs in all biological organisms. The 
biological aspects of aging are evolutionary conserved across eukaryotes. 
Saccharomyces cerevisiae being a unicellular eukaryote has been used as a model 
organism to study aging. This unicellular eukaryote has a short lifespan, a fully sequenced 
genome and it is easy to manipulate genetically to make changes in metabolic pathways. 
Hence, it has been historically used to identify genes, metabolic pathways and chemical 
compounds that have influence on aging process. An extract from white willow bark 
(which is called PE21) was discovered in Dr. Vladimir Titorenko’s lab as the plant extract 
capable of extending the chronological lifespan (CLS) of Saccharomyces cerevisiae. 
Previous studies in the lab have shown that PE21 considerably alters the lipid 
composition of Saccharomyces cerevisiae. Lipids play crucial roles in many important 
pathways related to cellular signaling network, energy storage, membrane trafficking, 
membrane dynamics and apoptosis. Lipidomics is a relatively new research field that 
aims at characterizing lipid profiles. The characterization of lipids is a difficult process 
because of their diverse chemical and physical properties and due to lack of sensitive 
tools to study them. Only with the advent of mass spectrometry it became possible to 
characterize individual lipid species of various lipid classes. Herein, I have developed an 
optimized LC-MS/MS method to successfully identify and quantify many individual 
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species of 10 different lipid classes of Saccharomyces cerevisiae. The developed method 
was used to analyze the effects of PE21 on the lipid composition of Saccharomyces 
cerevisiae. Our findings support previous studies, which stipulate that PE21 alters the 
lipid composition of yeast cells. PE21 markedly decreases the concentration of free fatty 
acids, thus it has been hypothesized that PE21 increases the CLS of yeast cells by 
decreasing the rate of liponecrosis known to be induced by free fatty acids. To further test 
this hypothesis, four single gene-deletion mutant strains differently affected in the 
metabolism of free fatty acids have been studied. More specifically, the lipid compositions 
and viabilities of such mutant strains were analyzed in yeast cultured in the presence or 
absence of PE21, and the results were compared to the results for wild-type strain.  
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1.0 Introduction 
1.1 Biological aging and its complexity 
Aging is a highly complex multifactorial phenomenon that affects all biological 
organisms. It is marked by the progressive decline in the ability of an organism to resist 
stress and damage [1 - 4]. This continuous decrease in the organism’s capacity to function 
leads to various pathologies such as neurodegenerative disorders, cancer and 
cardiovascular impairments and, ultimately, to death. Aging is orchestrated by an array 
of damage-producing and damage-repairing processes that are organized 
spatiotemporally throughout the life of an organism [2 – 9]. Current research aims at 
discovering and characterizing these processes to understand their integration by the 
organism and their specific roles in defining longevity. Another of current research’s focus 
is the discovery of small molecules that exhibit a geroprotective effect by extending 
lifespan and healthspan. Previous research has enumerated nine hallmarks of aging that 
span across the entirety of the life domains. These are epigenetic alterations, deregulated 
nutrient sensing, cellular senescence, altered intercellular communication, stem cell 
exhaustion, mitochondrial dysfunction, loss of proteolysis, telomere attrition and genomic 
instability [10]. Although these hallmarks have been studied extensively, much of the 
molecular mechanisms underlying them remain unknown. The current challenge is to fully 
characterize the different pathways and molecular mechanisms underlying aging in 
evolutionarily distant organisms. 
 
1.2  The signaling network that regulates longevity across phyla 
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 Many single-gene mutations that extend longevity have been discovered and 
characterized in yeast, worms, flies and mice. These mutations affect an array of proteins 
that are involved in many cellular processes such as cell cycle, cell growth, stress 
response, protein folding, apoptosis, autophagy, proteasomal protein degradation, actin 
organization, signal transduction, nuclear DNA replication, chromatin assembly and 
maintenance, ribosome biogenesis and translation, lipid and carbohydrate metabolism, 
oxidative metabolism in mitochondria, NAD+ 
homeostasis, amino acid biosynthesis and degradation, and ammonium and amino acid 
uptake [2 - 4, 7, 11 – 14]. Interestingly, these processes are controlled by a limited set of 
nutrient and energy-sensing signaling pathways that converge into a complex network 
that defines and regulates longevity through organismal and intracellular nutrient and 
energy-sensing mechanisms [7, 15 - 18]. 
 
One of these intracellular nutrient and energy-sensing  signaling pathways is the 
AMP-activated protein kinase/target of rapamycin (AMPK/TOR) pathway [17, 18]. This 
pathway is activated under conditions of low nutrient or energy supply by responding to 
high intracellular ratio of AMP to ATP. Under such conditions, TOR protein kinase is 
inhibited by AMPK. TOR protein kinase is known to associate with many other proteins 
into a complex known as TOR complex 1 (TORC1) [17, 18]. This complex responds to 
nutrient availability by phosphorylating and activating two nutrient-sensing protein 
kinases: Sch9 and protein kinase A (PKA) [14, 19]. TORC1 is a key player in many cellular 
processes; it  regulates translation, transcription, ribosome formation, nutrient transport 
across membranes and autophagy [14, 20]. Inhibition of TORC1 slows down many 
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energy-consuming processes and orchestrates a pro-longevity program that promotes  
several protective cellular processes such as autophagy to remove damaged 
macromolecules and organelles [17, 21 – 23], and Msn2/4-dependent transcription of 
stress response genes [24]. It has been shown that yeast, worms, flies and mice with 
reduced TORC1 activity exhibit an increase in both replicative and chronological 
lifespans. Akin to this, mutations that impair Sch9 and PKA extend longevity in yeast. It 
is thought that the combined action of TORC1, Sch9 and PKA suppresses the Msn2/4-
dependent transcription of stress response genes [19]. In fact, upon down-regulation of 
these kinases, both Msn2p and Msn4p translocate into the nucleus [25 - 27]. Upon their 
entry into the nucleus, these factors activate a transcriptional program that promotes the 
expression of many genes involved in stress protection, reactive oxygen species (ROS) 
detoxification, proteolysis, the tricarboxylic acid cycle, carbohydrate metabolism, 
trehalose biosynthesis and cell growth regulation [17 – 20].  
  
The cAMP/protein kinase A (cAMP/PKA) pathway is known to regulate longevity 
in evolutionarily distant organisms such as yeast and mice. Upon glucose deprivation, 
cAMP/PKA signaling is decreased through the attenuation of adenylate cyclase activators 
[36, 37]. Reduced levels of cAMP/PKA pathway inhibits the phosphorylation of Rim15p 
and two stress response transcription factors, Msn2p and Msn4p. This restores the 
activity of Rim15p and allows for the translocation of Msn2p and Msn4p into the nucleus 
[29 - 31]. These two proteins then promote Rim15p-dependent transcription of stress 
response genes The establishment of this pro-longevity transcriptional program extends 
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yeast chronological lifespan. Interestingly, both the AMPK/TOR and cAMP/PKA pathways 
converge onto Rim15p making it a nutritional integrator. 
 
1.3  Diets and pharmacological interventions that extend longevity across 
phyla 
Extensive evidence supports the idea that intracellular nutrient levels and energy 
status play pivotal roles in modulating the lifespan of different organisms. Two dietary 
interventions have been shown to have a considerable longevity-extending effect in 
organisms ranging from yeast to rhesus monkey. The first intervention is caloric restriction 
(CR). The CR diet is low in calories but does not compromise the supply of nutrients [38 
- 41]. The second intervention is dietary restriction (DR), which consists in reducing the 
levels of certain kinds of nutrients without compromising the intake of calories [42 - 45]. 
TORC1 plays the central role in the longevity-extending effects of CR and DR by 1) 
integrating the information on intracellular nutrient levels and energy status conveyed by 
AMPK, PKA and Sch9; and 2) serving as a control point that modulates a variety of 
longevity-defining processes. 
  
Like dietary regimens, there is a variety of pharmacological interventions that 
extend lifespan and healthspan in organisms across phyla. Some of these anti-aging 
compounds improve the lifespan of organisms and delay the onset of aging-related 
pathologies by targeting the AMPK/TOR signaling pathway, which is responsive to the 
intracellular nutrient and energy status of the organism. Rapamycin, also known as 
sirolimus [49], is a macrocyclic lactone produced by Streptomyces hygroscopicus [24, 
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50]. This chemical was first used for its antifungal properties as well as an 
immunosuppressant in renal transplant [51], but has been recently demonstrated alsoto 
have some pro-longevity characteristics. It acts by inhibiting TORC1 and thus allows for 
the downstream Msn2/4-mediated transcriptional program to take place, thus extending 
RLS and CLS in yeast [29, 52, 53]. This drug also extends longevity in fruit flies and mice 
[54, 55], as well as increases the replicative lifespan of cultured rodent fibroblasts, human 
epithelium and human fibrosarcoma cells [56]. Metformin is a pro-longevity moleculethat 
targets the AMPK/TOR signaling pathway by activating the AMPK; this reduces the 
activity of TORC1 signaling and extends longevity in worms and mice [57, 58]. 
Most of the currently known anti-aging compounds act as CR or DR-mimetics in 
that they extend longevity by targeting the same nutrient and energy-sensing signaling 
pathways as caloric restriction and dietary restriction. They also mimic the effects of these 
dietary regimens on gene transcription, metabolic processes and stress response 
pathways [59, 60]. Such compounds only increase lifespan under non-CR and non-DR 
conditions and are unable to do so when the nutrients or calories intake is limited [57, 61 
- 64].  
 
Lithocholic acid (LCA), on the other hand, was found out to be a powerful CR 
mimetic that delays yeast chronological aging [65]. This anti-aging compound extends the 
lifespan of chronologically aging yeast via two mechanisms. The first mechanism works 
under non-caloric restriction conditions and extends the lifespan of yeast by activating the 
anti-aging capacity of PKA. LCA regulates housekeeping longevity assurance pathways 
by inhibiting lipid-induced cellular necrosis, decreasing mitochondrial degradation, 
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changing redox reactions in mitochondria, increasing resistance against thermal and 
oxidative stresses, suppressing mitochondria-driven apoptosis, and increasing the 
stability and integrity of genomic and mitochondrial DNA. The second mechanism works 
in a calorie-independent way by regulating housekeeping longevity pathways that do not 
interfere with cAMP/PKA and AMPK/TOR pathways. LCA accumulates in the inner 
mitochondrial membrane and causes a remodeling of mitochondrial morphology by 
disturbing the asymmetrical distribution of phospholipids. The concentrations of 
phosphatidic acid (PA), phosphatidylcholine (PC), phosphatidylserine (PS) and 
phosphatidylglycerol (PG) are increased, whereas the concentration of 
phosphatidylethanolamine (PE) and cardiolipin (CL) are decreased [65]. These changes 
lead to an increase in mitochondrial size, a decrease in mitochondrial numbers and in an 
increase of mitochondrial abundance of cristae [65]. All these changes promote 
mitochondrial respiration, maintain the mitochondrial membrane potential, and enhance 
the efficiency of ATP synthesis in chronologically old cells, thus delaying the process of 
aging [65]. 
  
Recent research has revealed six plant extracts that significantly extend the 
chronological lifespan of yeast [66]. One of these plant extracts is the most potent aging-
delaying pharmacological intervention yet described in yeast. The detailed information 
about this plant extract and its effects can be found in Chapter 3.  
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1.4  Yeast is a valuable model organism to study the biology of aging and 
to uncover mechanisms that modulate aging 
Growing evidence supports the idea that the fundamental aspects of biological 
aging are evolutionarily conserved. This made the budding yeast Saccharomyces 
cerevisiae a valuable model organism to study the mechanisms underlying aging [14, 18, 
68]. Since this unicellular eukaryote has a short chronological lifespan, a fully sequenced 
genome and is easily amenable to genetic and biochemical manipulations [69], it has 
been successfully used for the discovery of genes, signaling pathways and dietary and 
pharmacological interventions that influence aging. In fact, baker’s yeast proves itself 
quite important in the identification of numerous longevity-defining genes, such as those 
that form a complex network of nutrient and energy-sensing pathways that modulate 
aging. Interestingly, these pathways have been found to govern aging processes in 
higher-order eukaryotes as well [14, 18, 49, 68, 70 – 72]. In yeast, there are two ways to 
study aging; the first monitors the replicative lifespan (RLS) and the second monitors the 
chronological lifespan (CLS). RLS is a measure of the maximum number of daughter cells 
that a mother cell produces before senescence [73]. RLS in yeast models aging of 
mitotically active and dividing mammalian cells, such as lymphocytes. In contrast, CLS in 
yeast is a measure of the length of time that a cell remains alive after it has entered a 
non-diving state [73]. CLS in yeast models aging in mammalian non-dividing cells, such 
as neurons. Under laboratory conditions, yeast chronological aging is studied using a 
clonogenic assay. This assay consists in the recovery of yeast cells at different timepoints 
and then measuring the fraction of cells that are alive in the population [74]. 
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1.5  Lipid metabolism in yeast 
Lipids are known to be essential for many cellular processes including the 
synthesis of membrane bilayers, energy storage, signal transduction, vesicular trafficking 
and apoptosis [75 - 77]. The organelles involved in the biosynthetic pathways of these 
lipids are the endoplasmic reticulum, peroxisomes, mitochondria and lipid droplets. The 
synthesis of these lipids is organized in a highly-ordered network which involves 
bidirectional transport of precursors and intermediate between all the organelles [75 - 77]. 
Phospholipids, such as PC, PE, PI, PS, as well as sphingolipids, are the building blocks 
for organellar and plasma membranes. These lipids are found in all types of organellar 
membranes of the cell, and their relative abundance of different lipid classes differ 
between these various membranes. It is believed that such differences in the 
concentrations of various lipid classes play essential roles in determining the function of 
each of these organelles. For example, cardiolipin is a mitochondria-specific 
diphosphatidylglycerol that has been shown to serve in many mitochondria-specific 
processes. Cardiolipin associates with five protein complexes of the mitochondrial 
respiratory chain and regulates their activities [78 - 85]. It also plays an important role in 
regulating the activity of cytochrome c [78 - 85]. This cytochrome c is essential for 
mitochondria-controlled apoptosis [78 - 85]. In addition, cardiolipin plays an essential role 
in maintaining the homeostasis of protein transport across the inner mitochondrial 
membrane and in sustaining the electrochemical gradient across this mitochondrial 
membrane [78 - 85]. Interestingly, specific alterations in the levels of CL have been 
associated with many pathologies and disorders, such as diabetic cardiomyopathy, ataxia 
and non-alcoholic fatty liver disease [80 - 83]. Reduced levels of this lipid have been 
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shown to promote aging in rodents and humans [78, 80, 83]. Lastly, triacylglycerol and 
steryl esters are neutral lipids that serve as storage lipid forms, as well as the 
detoxification hubs for free fatty acids and sterols [76]. These neutral lipids are deposited 
in lipid droplets and remain there until their breakdown is triggered in response to certain 
stimuli. 
 
1.6  Studying the lipid metabolism can provide insights on the 
mechanisms that underlie aging in yeast 
 A complex network that regulates lipid metabolism in yeast is divided into several 
metabolic pathways for various lipid classes, with each class being represented by many 
species that differ in the number of carbon atoms composing certain fatty acids and in the 
extent of unsaturation of these fatty acids [97, 98]. These lipids serve many function in 
cells such as, but not limited to, membrane dynamics, energy storage and signaling [98 - 
101]. Many conditions that lead to changes in metabolism such as dietary alterations or 
environment conditions can cause changes in the levels of lipids in the cell and in their 
relative concentrations. These lipid changes can provide an insight into the mechanisms 
underlying aging. By studying the lipidomic signature of a cell, which consists of a 
snapshot of the lipid profile (relative concentrations of different lipid classes and species) 
at a specific time point under specific conditions, much can be learned about the 
mechanisms that define the rate of aging. The lipid signature of long-lived yeast cells can 
be used to 1) study the mechanisms underlying aging across phyla; and 2) design and 
develop drugs that can be used to extend longevity by emulating the changes in the lipid 
profile of these long-lived yeast cells in higher-order eukaryotes such as humans. 
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 There are many methods for the identification and quantitation of lipids. The most 
predominant current technique to measure such lipid signatures is the electrospray 
ionization mass spectroscopy (ESI/MS), because of it  high resolution, high sensitivity and 
high speed of execution [97, 98]. ESI/MS allows to identify different lipid classes and their 
relative abundance, but cannot identify individual species within these classes. This is 
due to the highly similar fatty acyl chains  present in all major lipid classes [97, 98]. When 
combined with a well-developed sample extraction technique, intelligent selection of lipid 
standards, separation of the lipid classes prior to MS using HPLC and the use of 
bioinformatics tools to analyze the spectra obtained, ESI/MS allows an accurate 
characterization of the lipid signature of a yeast cell [102].  
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2.0 Development of an optimized LC-MS/MS method for the identification and 
quantification of various lipid classes and numerous lipid species in each 
class of Saccharomyces cerevisiae 
 
2.1 Introduction. 
  2.1-1 Background  
Lipidomics is a relatively new emerging research field due to its crucial role in 
studying many important pathways related to lipid-based cellular signaling networks, 
energy storage, membrane trafficking, membrane dynamics and apoptosis [103-106]. 
One of the most important group of lipids is the group of phospholipids, which are known 
to regulate most of the above pathways. Phospholipids are composed of a polar head 
group and a glycerol backbone for the attachment of different fatty acid moieties. The fatty 
acid moieties of different phospholipid classes of yeast cells are mostly the palmitic 
(C16:0), palmitoleic (C16:1) and oleic (C18:1) acids [107,108]. The fatty acid moieties of 
phospholipids found in yeast cells are either fully saturated or mono-unsaturated, since 
yeast cells have only one acyl desaturase enzyme [109,110]. Better understanding of the 
roles that different classes of phospholipids play in various cellular processes depends 
on their physical and chemical properties as well as on their concentrations.  
 Historically, the diverse structural and chemical properties of phospholipids and 
other lipid classes were obstacles in  separating them from other impurities in the sample, 
identifying them and measuring their concentrations. For decades, high pressure liquid 
chromatography (HPLC) and thin layer chromatography (TLC) were the best choices to 
separate and characterize different lipid classes. However, it was impossible to use HPLC 
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and TLS for the identification and quantitation of individual species within each lipid class, 
due to low sensitivity and resolution of these techniques. Only with the advent of mass 
spectrometry technique, it became possible to identify individual phospholipid species 
with an accuracy of only one double bond difference in their fatty acid moieties [111]. 
Currently, there are many types of mass spectrometers used to analyze phospholipids 
and other lipid classes, such as triple quadrupole, quadrupole time of flight (TOF), LTQ 
orbitrap, ion trap and magnetic sector [112]. All these mass spectrometers have 
essentially three main components, including an ion source, mass analyzer and ion 
detector (as illustrated in Figure 1).  
	
Figure 1. Components of a typical mass spectrometer, which contains an inlet where the sample in solution 
is injected, an ion source to ionize the sample, a mass analyzer that takes ionized masses and separates 
them based on mass-to-charge ratios, and an ion detector [113]. 
 
Therefore, they all operate on the same principle, but due to different type of ion source, 
mass analyzer and ion detector different mass spectrometers are used for analyzing 
different aspects of phospholipids. Reliable mass spectrometer data depends on the 
method of ionization and sample introduction. The use of mass spectrometer to analyze 
phospholipids was hindered due to extensive fragmentation by the ion source until the 
advent of electrospray ionization (ESI) which is a soft ionization method [114]. ESI cause 
almost no fragmentation of the parent ion, thus all phospholipids can be detected as 
molecular ions, which is necessary for structural analysis of lipid species [114]. The 
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principle of ionization in electrospray ionization is that sample passes through an 
extremely think capillary tube at a slow rate. At the end of the capillary tube a strong 
voltage difference nebulizes the sample together with mobile phase intro small charged 
droplets [114]. In the ESI lipid ions are produced by addition of a proton or any other 
cation, or multiple charge cation or by removal of a proton [115]. 
 Although the combination of ESI with mass spectrometry was a big success in the 
field of lipidomics, but the advent of tandem mass spectrometry and its combination with 
ESI truly revolutionized the analysis of phospholipids [116, 117]. Tandem mass 
spectrometry (MS/MS) is the most recent technology which has an extra step of inducing 
collision of molecular ions between the two mass analyzers with a neutral atom or 
molecule as its illustrated in figure 2. 
 	
Figure 2. Tandem mass spectrometer in CID fragmentation setting. Q1 and Q3 quadrupoles are acting as 
mass analyzers, Q2 is a collision cell. The parent ion studied is chosen by Q1 and passes to the collision 
cell Q2. The molecular ion is fragmented by collision-induced dissociation (CID) and the mass-to-charge 
rations are read by Q3 [113]. 
 
The fragmentation of molecular ions in the collision chamber is referred to as collision 
induced dissociation (CID) [115]. In tandem mass spectrometry, we can easily assign a 
mass spectrometer peak to a specific lipid species, since the first mass analyzer selects 
the precursor or molecular ion, then it is passed to collision chamber where it dissociates 
into many smaller fragments. The structural information can be obtained through analysis 
of precursor ion and the fragments generated by collision, since each phospholipid has a 
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specific pattern of fragments [111]. The task of putting together the fragments back is 
done by computer software such as lipid-search or any other MS/MS compatible software. 
Even though ESI combined with tandem mass spectrometer can deduce the structural 
information of a lipid species, but if the lipid sample is not purified well enough and if you 
infuse the sample directly into mass spectrometer; there will be many problems assigning 
the mass spectrometer peaks to their corresponding lipid species. 
 
2.1-2 Comparison of the shot gun and LC-MS/MS techniques of lipid 
analysis. 
In the direct infusion or famously known as shot gun lipidomics, the purified sample 
is directly injected in the inlet of mass spectrometer, after passing through the ionization 
capillary a selected range of molecular ions will pass through the first mass analyzer into 
the collision chamber [107 – 111]. The problem is that the first mass analyzer does not 
pass the ions one by one to the collision chamber, so that we deduce the structural 
information of each individual lipid species based on its unique fragmentation pattern. 
Instead many ions are passed at once to collision chamber, and we can only determine 
the different types of phospholipid classes within a sample due to distinct fragment 
patterns of the polar head groups of each phospholipid class; it is not possible to associate 
the fragment of different fatty acid moieties to the right lipid species to which it belongs 
to. Therefore, shotgun technique is only good to quickly determine the different classes 
of phospholipids in a sample, but it is not possible to identify and quantify individual lipid 
species within each class if a mixture of lipid species is injected at once. However, it is 
possible to deduce the structure of a target phospholipid if we have the prior knowledge 
	 15	
of that phospholipid. In the first mass analyzer, a specific molecular ion mass 
corresponding to the target molecular ion can be selected, so that only that specific 
molecular ion pass to the collision chamber not the lipid species present in the mixture. 
This procedure of lipid identification needs prior knowledge of lipid species m/z value also 
it is very time consuming.  
 LC-MS/MS on the other hand can solve the problems encountered by the direct 
infusion. In the LC-MS/MS as the name suggest high pressure liquid chromatography 
HPLC is attached to a tandem mass spectrometer. The advantage of such setup is that 
HPLC will elute lipid species separately if the right column, mobile phase and the additives 
are chosen. The reverse phase –HPLC (RP-HPLC) which has a hydrophobic stationary 
phase separates lipid species based on their lipophilicity. Therefore RP-HPLC separation 
is based on the fatty acid moieties; it will elute two species of same molecular weight and 
charge if they differed by only one single double bond [115]. The high resolving power of 
HPLC also eliminates the problem of isobaric species. Isobaric species are those species 
with identical molecular weight, but differ in their structure [118].  
 
 2.1-3 Selection of an appropriate HPLC column for lipid analysis.  
Phospholipids can be separate by both normal phase HPLC (NP-HPLC) and 
reverse phase HPLC (RP-HPLC). Phospholipids are amphiphilic molecules which have a 
hydrophilic head group and hydrophobic fatty acid moiety [108]. NP-HPLC has a polar 
stationary phase and it separates phospholipids based on their increasing head group 
polarity. So, the elution starts with least polar head phosphatidylglycerol (PG) and other 
lipid classes will elute in the following sequence: phosphatidylinositol (PI), 
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phosphatidylethanolamine (PE), phosphatidylserine (PS), phosphatidylcholine (PC) and 
sphingomyelin (Sph). NP-HPLC is good choice for separation and quantification of 
different classes of phospholipids, since a single phospholipid class will elute at one time, 
but it is not a good choice if the purpose of the study is to analyze individual lipid species 
within a specific class.  
 RP-HPLC is the column of choice if the goal is to analyze individual lipid species 
in various classes. RP-HPLC elutes the phospholipids classes in the reverse order 
compare to the NP-HPLC. Therefore, the phospholipid with least polar head such as PG 
will be eluted at last. A specific type of RP-HPLC is charged-surface-hybrid (CSH) which 
has slightly charged surface can elute molecules based on both the hydrophilic and 
hydrophobic characteristics. Thus, CSH column elutes phospholipid classes both based 
on their polar head groups and hydrophobic fatty acid moieties. Therefore, CSH column 
has a very high resolving power, which elutes the members of the same lipid class if they 
differ by a single double bond [112]. The drawback of RP-HPLC is that the polar impurities 
elutes with target molecules together. The polar impurities reduce the efficiency of ESI 
ionization through process known as ion suppression [115].  
  
 2.1-4 Selection of appropriate mobile phases and mobile phase additives 
In general LC-MS/MS efficiency and sensitivity depends on ionization of target 
molecules. If a sample has a mixture of lipid classes, then each of the class will have an 
ideal ionization condition. Therefore, it is difficult to find a single ionization condition to 
achieve the optimal ionization of all lipid classes. As a result, the bet ionization condition 
is the one which result in a good ionization of overall lipid classes. The only two salts 
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which are incompatible with electrospray ionization are phosphate and sulfate containing 
salts [117]. mostly ammonium formate and ammonium acetate are used together with 
minute quantities of formic acid or acetic acid to obtain best ionization by altering the pH. 
The effect of different salts and acids on ionization of lipid classes are further discussed 
in tables 5 and 6.  
 The choice of mobile phase is strictly dependent on the sample type and on the 
column type [119]. the extensively used mobile phases for lipid analysis are acetonitrile, 
isopropanol, methanol and water. Almost always each specific sample has a unique 
HPLC gradient due to difference in MS peak quality and retention time of individual 
molecules within in a sample. For details of HPLC gradient please refer to the material 
and method section.  
 
2.2 Detailed Materials and Methods  
2.2-1 Yeast strains, media and growth conditions 
The wild-type strain Saccharomyces cerevisiae BY4742 (MATa his3D1 leu2D0 
lys2D0 ura3D0) from Thermo Scientific/Open Biosystems was grown in a synthetic 
minimal YNB medium (0.67% Yeast Nitrogen Base without amino acids) initially 
containing 2% (w/v) glucose and supplemented with 20 mg/l histidine, 30 mg/l leucine, 30 
mg/l lysine and 20 mg/l uracil. Cells were cultured at 30 oC with rotational shaking at 200 
rpm in Erlenmeyer flasks at a “flask volume/medium volume” ratio of 5:1.  
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2.2-2 Cell collection and counting  
A hemocytometer (Hausser Scientific Catalog# 3200) was used to count yeast 
cells and to calculate the volume of cell culture containing 5.0 x 107 cells. Appropriate 
volume of cell culture was taken, and the cells were harvested by centrifugation in a 
Centra CL2 clinical centrifuge at 3,000 × g for 5 min at room temperature. The cell pellet 
was washed once in ice-cold Nano-pure water and once in ice-cold 155 mM ammonium 
bicarbonate (pH 8.0), and the cells were subjected to centrifugation at 20000 × g for 1 
min at room temperature. The cell pellet was stored at -80 oC until lipid extraction.  
 
2.2-3 Dichloromethane/Methanol lipid extraction method 
For lipid extraction, the pelleted cells kept at -80 oC were thawed on ice before 
being re-suspended in 200 µl of ice-cold Nano-pure water. The re-suspended sample 
which contained 5 × 107 cells was transferred to a 15-mL high-strength glass screw top 
centrifuge tube with a Teflon lined cap (#0556912; Fisher Scientific). To each 15-mL high-
strength glass tube the following was added: 1) 25 µL of the internal standard mix 
prepared in mixture of dichloromethane: methanol (both OPTIMA grade from Fisher 
Scientific used for LC-MS with CAS# 75-09-2 and 67-56-1), 2) 100 μL of 425-600 μM 
acid-washed glass beads to break open the cells (#G8772; Sigma-Aldrich) and 600 µL of 
dichloromethane : methanol at a 17:1 ratio both from Fisher Scientific with OPTIMA grade 
and CAS# 75-09-2 and 67-56-1. The samples were then vortexed vigorously for 5 minute 
at room temperature to breakdown the cells and subjected to centrifugation in a Centra 
CL2 clinical centrifuge at 3,000 × g for 5 min at room temperature; this centrifugation 
allowed to separate the upper aqueous phase from the lower organic phase, which 
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contained nonpolar lipids TAG, PC, PE and PG. The lower organic phase (400 µL) was 
then transferred to another 15-mL high-strength glass screw top centrifuge tube using 
pipette with polypropylene gel loading tips (Fisher scientific catalog# 13-611-115) with 
careful attention not to disrupt the glass beads or upper aqueous phase. 300 µL of 
Dichloromethane:methanol (2:1) solution was added to the remaining upper aqueous 
phase to allow the extraction of sphingolipids and of polar lipids PA, PS, PI and CL. The 
samples were again vortexed vigorously at room temperature for 5 minutes. The initial 
separated organic band was kept at under the flow of nitrogen gas for the duration of the 
second vortexing. The samples were again centrifuged for 5 min at 3,000 × rpm at room 
temperature; the lower organic phase (200 µL) was then separated and added to the 
corresponding initial organic phase with pipette using the polypropylene gel loading tips. 
With both lower organic phases combined, the solvent was evaporated off by nitrogen 
gas flow. Once all solvent was evaporated, the tubes containing the lipid film were closed 
under the flow of nitrogen gas and stored in -80oC. 
 
2.2-4 Chloroform/Methanol lipid extraction method 
For lipid extraction, the pelleted cells kept at -80 oC were thawed on ice before 
being re-suspended in 200 µl of ice-cold Nano-pure water. The re-suspended sample 
which contained 5 × 107 cells was transferred to a 15-mL high-strength glass screw top 
centrifuge tube with a Teflon lined cap (#0556912; Fisher Scientific). To each 15-mL high-
strength glass tube the following was added: 1) 25 µL of the internal standard mix 
prepared in mixture of chloroform: methanol (both OPTIMA grade from Fisher Scientific 
used for LC-MS with CAS# 76-09-3 and 67-56-1), 2) 100 μL of 425-600 μM acid-washed 
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glass beads to break open the cells (#G8772; Sigma-Aldrich) and 600 µL of chloroform : 
methanol at a 17:1 ratio both from Fisher Scientific with OPTIMA grade and CAS# 76-09-
3 and 67-56-1. The samples were then vortexed vigorously for 5 minute at room 
temperature to breakdown the cells and subjected to centrifugation in a Centra CL2 
clinical centrifuge at 3,000 × g for 5 min at room temperature; this centrifugation allowed 
to separate the upper aqueous phase from the lower organic phase, which contained 
nonpolar lipids TAG, PC, PE and PG. The lower organic phase (400 µL) was then 
transferred to another 15-mL high-strength glass screw top centrifuge tube using pipette 
with polypropylene gel loading tips (Fisher scientific catalog# 13-611-115) with careful 
attention not to disrupt the glass beads or upper aqueous phase. 300 µL of chloroform-
methanol (2:1) solution was added to the remaining upper aqueous phase to allow the 
extraction of sphingolipids and of polar lipids PA, PS, PI and CL. The samples were again 
vortexed vigorously at room temperature for 5 minutes. The initial separated organic band 
was kept at under the flow of nitrogen gas for the duration of the second vortexing. The 
samples were again centrifuged for 5 min at 3,000 × rpm at room temperature; the lower 
organic phase (200 µL) was then separated and added to the corresponding initial organic 
phase with pipette using the polypropylene gel loading tips. With both lower organic 
phases combined, the solvent was evaporated off by nitrogen gas flow. Once all solvent 
was evaporated, the tubes containing the lipid film were closed under the flow of nitrogen 
gas and stored in -80oC. 
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2.2-5 Methyl-tert-butyl-ether (MTBE)/Methanol lipid extraction method 
For lipid extraction, the pelleted cells kept at -80 oC were thawed on ice before being re-
suspended in 200 µl of ice-cold Nano-pure water. The re-suspended sample which 
contained 5 × 107 cells was transferred to a 15-mL high-strength glass screw top 
centrifuge tube with a Teflon lined cap (#0556912; Fisher Scientific). To each 15-mL high-
strength glass tube the following was added: 1) 25 µL of the internal standard mix 
prepared in mixture of MTBE: methanol (both OPTIMA grade from Fisher Scientific used 
for LC-MS with CAS# 78-01-5 and 67-56-1), 2) 100 μL of 425-600 μM acid-washed glass 
beads to break open the cells (#G8772; Sigma-Aldrich) and 1.5 ml of ice-cold methanol 
was added. The samples were then vortexed vigorously for 5 minute at room temperature 
to breakdown the cells. 5 ml of ice-cold MTBE was added to sample and the sample was 
incubated at room temperature in a shaker for 1 hour. Phase separation was induced by 
addition of 1.25 ml ice-cold water and incubated on ice for 10 minutes. After the sample 
was subjected to centrifugation in a Centra CL2 clinical centrifuge at 3,000 × g for 5 min 
at room temperature; this centrifugation allowed to separate the upper organic phase from 
the lower aqueous phase. The upper organic phase was then transferred to another 15-
mL high-strength glass screw top centrifuge tube using pipette with polypropylene gel 
loading tips (Fisher scientific catalog# 13-611-115) with careful attention not to disrupt the 
glass beads or lower aqueous phase. 2 ml of extraction solvent was added to remaining 
sample in aqueous phase to re-extract the lipids. The extraction solvent mixture contains 
MTBE/methanol/water at ratio of 10:3:2.5 (v/v/v). The initial separated organic band was 
kept at under the flow of nitrogen gas for the duration of the second vortexing. The upper 
organic phase was added to the corresponding initial organic phase with pipette using the 
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polypropylene gel loading tips. With both organic phases combined, the solvent was 
evaporated off by nitrogen gas flow. Once all solvent was evaporated, the tubes 
containing the lipid film were closed under the flow of nitrogen gas and stored in -80oC. 
 
 
 
Detection 
mode 
Lipid classes 
Lipid chain 
composition 
Calculated 
M/Z values 
Moles in 
samples 
Negative 
Ceramide (18:1/17:0) 550.5204675 2.26E-09 
Cardiolipin (14:0/14:0/14:0/14:0)  1239.839755 
1.96E-09 
Free Fatty Acid 19:0 297.2799035 
8.37E-09 
phosphatidylethanolamine (15:0/15:0) 662.4766305 3.77E-09 
Phosphatidylglycerol (15:0/15:0) 693.4712115 3.49E-09 
phosphatidylinositol (17:0/20:4) 871.5342065 3.00E-11 
phosphatidylserine (17:0/17:0) 762.5290605  
3.18E-09 
Positive 
phosphatidylcholine (13:0/13:0)  650.4755335 
3.85E-09 
phytosphingosine (16:1)  272.2584055 
2.25E-09 
triacylglycerol (28:1/10:1/10:1) 818.7232155 3.67E-09 
Table 1. Internal lipid standards used for the experiment. Note: Internal lipid standards CL, CER, 
PI, SO, PE, PG, FFA, PS and PC were all from Avanti Polar Lipid, Alabaster, AL, USA. TAG internal 
standard originates from Larodan, Malmo, Sweden.  
	
	 23	
	
2.2-6 Sample preparation for LC-MS/MS  
500 µL of acetonitrile: 2-propanol: H2O with ratio of (65:35:5) all with LC-MS grade 
from Fisher Scientific (catalog# A9551, A4611 and W6212 ) added to tubes containing 
the lipid film. Each tube was vortexed 3 times for 10 seconds each time and then all the 
samples were sonicated for 15 minutes and vortexed again as above and 100 µL from 
each sample was added to glass vials with inserts used for Agilent1100 Wellplate (note: 
it is important to eliminate all the air bubbles in the insert before putting the vials in the 
Agilent1100 Wellplate). 
2.2-7 Liquid chromatography conditions 
The LC–MS experiments were performed using an Agilent 1100 series LC system 
(Agilent Technologies) equipped with a binary pump, de-gaser and an autosamples. Lipid 
species were separated on a reverse-phase column CSH C18 (2.1 mm; 75 mm; pore size 
130 Å; pH range of 1-11) (Waters, Milford, MA, USA) coupled to a CSH C18 VanGuard 
(Waters). The column was maintained at 55 °C at a flow-rate of 0.3 mL/min. The mobile 
phases consisted of (A) 60:40 (v/v) acetonitrile: water and (B) 90:10 (v/v) isopropanol: 
acetonitrile. For the positive mode ESI (+) both mobile phases A and B were mixed with 
10 mM ammonium formate (0.631 g/L) from Fisher Scientific (catalog# A115-50). For the 
negative mode ESI (-) both mobile phases A and B were mixed with 10 mM ammonium 
acetate (0.771 g/L) from Fisher Scientific (catalog# 631-61-8). To enhance solubilizing of 
ammonium formate and ammonium acetate both salts were dissolved first in small 
volume of water (50 µl) before their addition in the mobile phases. Each mobile phase 
with modifiers (ammonium formate and ammonium acetate) was mixed, sonicated for 20 
minutes to achieve complete dissolving of modifiers, mixed again, and then sonicated for 
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another 20 minutes. 
The separation of different lipid species by HPLC was achieved under the following 
HPLC gradient: 0 to 4 min 90%(A); 4 to 10 min 40%(A); 10 to 21 min 32% (A); 21 to 24 
min 3 % (A); 24 to 33 min 90 % (A). A sample volume of 5 µl and 10 µl was used for the 
injection in ESI (+) and ESI (-) respectively. Samples were kept in the Agilent1100 
Wellplate. 
2.2-8 Mass spectrometry 
Extracted lipids were separated by HPLC and analyzed with Thermo Orbitrap 
Velos Mass Spectrometer equipped with ESI ion source (Thermo Scientific). Parent ions 
(MS-1) were detected in positive and negative modes using the FT analyzer at a 
resolution of 60,000. The MS-1 mass range used is from 150 – 2000 Dalton.  
Ion Source type ESI 
Capillary Temperature oC 300 
Source heater Temperature oC 300 
Sheath Gas Flow 10 
Aux Gas flow 5 
Table 2. Thermo Orbitrap Velos mass spectrometer’s tune file instrument settings. Legend: ESI 
stands for electrospray ionization.  
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Instrument polarity Positive Negative 
Activation type HCD CID 
Min. signal required 5000 5000 
Isolation Width 2.0 2.0 
Normalized Collision energy 55.0 35 
Default charge state 2 2 
Activation time 0.1 10 
Table 3. Instrument method for MS-2 used in this experiment. Legend: HCD stands for High-energy-
induced-collision-dissociation, and CID stands for collision-induced-dissociation.  
 
2.2-9 Processing of raw data from LC-MS 
Raw files from LC-MS were analyzed by Lipid Search software (V4.1) from Thermo 
Fisher. The Lipid Identification Software “Lipid Search” was used to identify different lipid 
classes with the help of Molecular Fragmentation Query Language based on the below 
(Table 4) parameters. In addition to the parameters below (Table 4) an extra manual filter 
was applied to eliminate any Fatty Acid with odd number of carbon and to eliminate any 
fatty acid with more than 1 double bond (polyunsaturated fatty acid).  
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Identification  
Database Orbitrap 
Peak detection Recall isotope (ON) 
Search option Product search Orbitrap 
Search type Product 
Experiment type LC-MS 
Precursor tol 10 ppm 
Product tol 
HCD (positive mode) 20 ppm 
CID (negative mode) 0.5 da 
 Quantitation  
Execute quantitation ON 
Mz tol -5.0; +5.0 
Tol type ppm 
Filter 
Top rank filter ON 
Main node filter Main isomer peak 
m-score threshold 5.0 
c-score threshold 2.0 
FFA priority ON 
ID quality filter 
A Lipid class & FA are completely identified 
B Lipid class & some FA are identified 
C Lipid class or FA are identified 
D Lipid identified by other fragment ions (H2O 
and others) 
 Lipid Class  
HCD (positive) PC, SO, TG 
CID (negative) CER, CL, FA, PE, PG, PI, PS 
Ions 
HCD (positive) +H, +NH4, +Na 
CID (negative) -H, -2H, +HCOO 
Table 4. The parameters for lipid search software (V 4.1) used in the experiment for lipid detection. 
Legend: HCD stands for High-energy-induced-collision-dissociation, and CID stands for collision-induced-
dissociation. 
2.3 Results tables and figures. 
  
Lipid Standard ESI mode AmF AmF/FA AmAc AmAc/AA AmAc/FA 
Ceramide - 49.6 38.8 77.7 73.4 70.2 
Cardiolipin - 78.8 73.2 88. 85.3 81.0 
Free Fatty Acid - 92.4 94 92.6 91.8 94.2 
Phosphatidylethanolamine - 73.4 61.5 77.7 74.5 75.6 
Phosphatidylglycerol - 34.5 38.8 43.2 45.3 42.1 
Phosphatidylinositol - 72.3 70.2 75. 76.6 73.4 
Phosphatidylserine - 75.6 74.5 81 77.7 69.1 
Phosphatidylcholine + 86.4 81 54 57.2 59.4 
Phosphatidylsphingosine + 88.5 84.2 74.5 75.6 70.2 
Triacylglycerol + 97.2 89.6 75.6 77.7 81 
Table 5. The effect of different mobile phase additives on the efficiency of ionization of lipid 
standards: Ionization source used is electrospray ionization (ESI) and the HPLC column used is a normal 
phase column (NP-HPLC). The values in this table is from the average of 5 replicates as percentage (%) 
of the highest peak intensity value detected in each set. Legend: AmF ammonium formate, AmF/FA 
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ammonium formate with formic acid, AmAc ammonium acetate, AmAc/AA ammonium acetate with acetic 
acid, AmAc/FA ammonium acetate with formic acid. The highest values for ionization efficiencies in both + 
and - modes of ESI are highlighted in green.  
   
Lipid Standard ESI mode AmF AmF/FA AmAc AmAc/AA AmAc/FA 
Ceramide - 74 75.2 85.8 77 74.8 
Cardiolipin - 72.9 75.1 78.3 68.4 74 
Free Fatty Acid - 77.1 77.2 75.5 84 72.9 
Phosphatidylethanolamine - 98 96 95 91.5 86 
Phosphatidylglycerol - 64 45.1 75.9 60.5 55 
Phosphatidylinositol - 79.3 76 82.5 80.3 77 
Phosphatidylserine - 73.7 61.6 85.8 81.4 73.7 
Phosphatidylcholine + 93.5 86.9 69.3 60.5 62.7 
Phosphatidylsphingosine + 89.1 79.2 78.1 73.7 69.3 
Triacylglycerol + 92.4 88 86.9 80.3 84.7 
Table 6. The effect of different mobile phase additions on the efficiency of ionization of lipid 
standards: Ionization source used is electrospray ionization (ESI) and the HPLC column used is a reversed 
phase column (RP-HPLC). The values in this table is from the average of 5 replicates as percentage (%) 
of the highest peak intensity value detected in each set. Legend AmF ammonium formate, AmF/FA 
ammonium formate with formic acid, AmAc ammonium acetate, AmAc/AA ammonium acetate with acetic 
acid, AmAc/FA ammonium acetate with formic acid. The highest values for ionization efficiencies in both + 
and - modes of ESI are highlighted in green. 
 
Table 7. The efficiencies of methyl-tert-butyl-ether (MTBE) and methanol extraction methods 
evaluated using commercial lipid standards: Ionization source used is electrospray ionization (ESI) 
and the HPLC column used is a reversed phase column (RP-HPLC). The values in this table is from the 
average 3 replicates and they represent percentage (%) recovery of lipid standards from the extraction 
compare to the same concentration of lipid standards spiked directly in the MS injection solvent. Legend 
AmF ammonium formate, AmAc ammonium acetate. 
 
 
 
 
 
Lipid Standard ESI mode AmF AmAc 
Ceramide - 48.1 57.4 
Cardiolipin - 47.3 52.4 
Free Fatty Acid - 50.1 50.5 
Phosphatidylethanolamine - 63.7 63.6 
Phosphatidylglycerol - 41.6 50.8 
Phosphatidylinositol - 0 0 
Phosphatidylserine - 0 0 
Phosphatidylcholine + 60.7 46.4 
Phosphatidylsphingosine + 57.9 52.3 
Triacylglycerol + 60.0 58.2 
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Lipid Standard ESI mode AmF AmAc 
Ceramide - 59.9 71.2 
Cardiolipin - 59.0 64.9 
Free Fatty Acid - 62.4 62.6 
Phosphatidylethanolamine - 79.3 78.8 
Phosphatidylglycerol - 51.8 62.9 
Phosphatidylinositol - 64.2 68.4 
Phosphatidylserine - 59.6 71.2 
Phosphatidylcholine + 75.7 57.5 
Phosphatidylsphingosine + 72.1 64.8 
Triacylglycerol + 74.8 72.1 
Table 8. The efficiency of 17:1 Dichloromethane:methanol and 2:1 Dichloromethane:methanol 
extraction method on the lipid standards: Ionization source used is electrospray ionization (ESI) and 
the HPLC column used is a reversed phase column (RP-HPLC). The values in this table is from the 
average 3 replicates and they represent percentage (%) recovery of lipid standards after the extraction 
compare to the same concentration of lipid standards spiked directly in the MS injection solvent. Legend 
AmF ammonium formate, AmAc ammonium acetate. 
 
Lipid Standard ESI mode AmF AmAc 
Ceramide - 64.3 77.2 
Cardiolipin - 63.4 70.4 
Free Fatty Acid - 67.0 67.9 
Phosphatidylethanolamine - 85.2 85.5 
Phosphatidylglycerol - 55.6 68.3 
Phosphatidylinositol - 68.9 74.2 
Phosphatidylserine - 64.1 77.2 
Phosphatidylcholine + 81.3 62.3 
Phosphatidylsphingosine + 77.5 70.2 
Triacylglycerol + 80.3 78.2 
Table 91. The efficiency of 17:1 Chloroform:methanol and 2:1 Chloroform:methanol extraction 
method on the lipid standards: Ionization source used is electrospray ionization (ESI) and the HPLC 
column used is a reversed phase column (RP-HPLC). The values in this table is from the average 3 
replicates and they represent percentage (%) recovery of lipid standards after the extraction compare to 
the same concentration of lipids spiked directly in the MS injection solvent. Legend AmF ammonium 
formate, AmAc ammonium acetate. The highest values for extraction efficiencies in both + and - modes 
of ESI are highlighted in green. 
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Lipid Standard ESI mode AmF AmAc 
Ceramide - 75 83.8 
Cardiolipin - 70.9 79.3 
Free Fatty Acid - 76.1 74.5 
Phosphatidylethanolamine - 98 95 
Phosphatidylglycerol - 64 75.9 
Phosphatidylinositol - 79.3 82.5 
Phosphatidylserine - 71.5 84.8 
Phosphatidylcholine + 52.3 60.5 
Phosphatidylsphingosine + 78.4 75.2 
Triacylglycerol + 65.7 69.7 
Table 10. The effect of high-energy collisional dissociation (CID) on the percentage of product-ion 
yield for commercial lipid standards: The values in this table represent the average of 3 replicates as 
the percentage (%) of the highest peak intensity value detected in all 6 replicates (3 replicates in CID, and 
3 replicates in HCD). Legend: AmF ammonium formate, AmAc ammonium acetate. The highest values 
for product-ion yields in both + and - modes of ESI are highlighted in green. 
 
Lipid Standard ESI mode AmF AmAc 
Ceramide - 68.4 65.4 
Cardiolipin - 74.3 75.2 
Free Fatty Acid - 84.2 81.2 
Phosphatidylethanolamine - 85.1 73.1 
Phosphatidylglycerol - 68.4 67.1 
Phosphatidylinositol - 58.7 55.8 
Phosphatidylserine - 67.4 68.5 
Phosphatidylcholine + 92.5 65.3 
Phosphatidylsphingosine + 87.1 75.1 
Triacylglycerol + 91.4 84.9 
Table 11. The effect of high-energy collisional dissociation (HCD) on the percentage of product-
ion yield of the lipid standards: The values in this table represent the average of 3 replicates as the 
percentage (%) of the highest peak intensity value detected in all 6 replicates (3 replicates in CID, and 3 
replicates in HCD). Legend: AmF ammonium formate, AmAc ammonium acetate. The highest values for 
product-ion yields in both + and - modes of ESI are highlighted in green. 
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Lipid Class Fatty Acid Moieties Ionization Type MS Peak Area Calculated m/z Values 
PC (16:0/10:0) M+H 2.13E+08 650.4755 
PC (8:0/8:0) M+H 2.30E+06 494.3241 
PC (8:0/8:0) M+H 1.09E+05 496.3398 
PC (8:0/10:0) M+H 6.38E+05 522.3554 
PC (8:0/10:0) M+H 4.49E+05 524.3711 
PC (16:1/12:0) M+H 1.58E+06 676.4912 
PC (16:0/12:0) M+H 2.23E+06 678.5068 
PC (16:1/14:0) M+H 3.33E+06 704.5225 
PC (16:0/14:0) M+H 9.26E+05 706.5381 
PC (16:0/16:1) M+H 6.91E+07 732.5538 
PC (16:0/18:1) M+H 3.37E+07 760.5851 
PC (18:0/18:1) M+H 6.38E+06 788.6164 
PC (16:1/10:0) M+H 4.85E+05 648.4599 
PC (16:0/16:0) M+H 5.29E+06 734.5694 
PC (18:0/16:0) M+H 1.56E+06 762.6007 
PC (18:0/24:1) M+H 3.10E+06 872.7103 
PC (20:0/24:1) M+H 9.28E+05 900.7416 
PC (10:0/16:0) M+H 4.39E+05 636.4963 
Table 12. Lipid species of phosphatidylcholine identified by the optimized LC-MS/MS method. The lipid 
species represented here are from 7 growth time points (DME, D0, D1, D2, D4, D6, D8). Legend: DME stands for 
day mid-exponential phase. D stands for day and numeric values represent days of growth. The highlighted in 
yellow row is for the lipid standard of phosphatidylcholine. 
	
	
	
Lipid Class	 Fatty Acid Moieties	 Ionization Type	 MS Peak Area	 Calculated m/z Values	
So	 (16:1)	 M+H	 1.26E+06	 272.2584	
So	 (16:0)	 M+H	 4.64E+07	 274.2741	
So	 (20:0)	 M+H	 3.71E+06	 346.3316	
So	 (22:1)	 M+H	 4.55E+06	 356.3523	
So	 (22:1)	 M+H	 3.13E+05	 372.3472	
So	 (22:0)	 M+H	 2.16E+07	 374.3629	
So	 (18:0)	 M+H	 5.43E+05	 302.3054	
So	 (18:0)	 M+H	 1.13E+06	 318.3003	
So	 (18:1)	 M+H	 3.11E+05	 300.2897	
Table 23. Lipid species of sphingomyelin identified by the developed LC-MS/MS method. The lipid species 
represented here are from 7 growth time points (DME, D0, D1, D2, D4, D6, D8). Legend: DME stands for day 
mid-exponential phase. D stands for day and numeric values represent days of growth. The highlighted in yellow 
row is for the lipid standard of sphingomyelin. 
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Lipid Class	 Fatty Acid Moieties	 Ionization 
Type	
MS Peak 
Area	
Calculated m/z Values	
TG	 (28:1/10:1/10:1)	 M+NH4	 1.27E+08	 818.7232	
TG	 (10:0/10:0/22:1)	 M+NH4	 1.32E+07	 738.6606	
TG	 (30:1/10:1/10:1)	 M+NH4	 2.06E+08	 846.7545	
TG	 (30:0/10:1/10:1)	 M+NH4	 2.26E+08	 848.7702	
TG	 (18:0/10:1/16:1)	 M+NH4	 2.62E+07	 764.6763	
TG	 (18:0/10:1/16:0)	 M+NH4	 7.01E+07	 766.6919	
TG	 (28:0/10:1/10:1)	 M+NH4	 4.13E+08	 820.7389	
TG	 (16:0/16:0/16:0)	 M+NH4	 1.07E+07	 824.7702	
TG	 (18:1/10:1/24:1)	 M+NH4	 1.21E+08	 874.7858	
TG	 (18:0/10:1/24:0)	 M+NH4	 2.15E+08	 878.8171	
TG	 (10:0/10:0/22:0)	 M+NH4	 1.67E+07	 740.6763	
TG	 (16:0/10:1/22:0)	 M+NH4	 1.46E+08	 822.7545	
Table 34. Lipid species of triglyceride identified by the developed LC-MS/MS method. The lipid 
species represented here are from 7 growth time points (DME, D0, D1, D2, D4, D6, D8). Legend: DME 
stands for day mid-exponential phase. D stands for day and numeric values represent days of growth. The 
highlighted in yellow row is for the lipid standard of triglyceride. 
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Lipid Class	 Fatty Acid Moieties	 Ionization Type	 MS Peak Area	 Calculated 
m/z Values	
Cer	 (d18:1/17:0)	 M-H	 3.36E+07	 550.5205	
Cer	 (16:0/16:0)	 M-H	 1.53E+05	 526.4841	
Cer	 (14:1/16:0)	 M-H	 2.93E+05	 528.427	
Cer	 (18:0/16:0)	 M-H	 3.98E+07	 554.5154	
Cer	 (18:0/22:0)	 M-H	 4.35E+04	 654.6042	
Cer	 (18:0/24:0)	 M-H	 3.27E+05	 682.6355	
Cer	 (18:0/26:0)	 M-H	 1.03E+07	 710.6668	
Cer	 (20:0/26:0)	 M-H	 1.16E+06	 738.6981	
Cer	 (18:0/4:0)	 M-H	 2.46E+04	 386.3276	
Cer	 (18:0/18:0)	 M-H	 3.31E+05	 598.5416	
Cer	 (18:0/20:0)	 M-H	 1.58E+05	 626.5729	
Cer	 (18:0/24:0)	 M-H	 5.54E+04	 666.6406	
Cer	 (18:0/26:0)	 M-H	 5.18E+05	 678.677	
Cer	 (18:0/26:0)	 M-H	 3.33E+06	 694.6719	
Cer	 (16:0/30:0)	 M-H	 5.95E+05	 722.7032	
Cer	 (12:0/4:0)	 M-H	 1.84E+05	 302.2337	
Cer	 (20:0/16:0)	 M-H	 4.51E+05	 582.5467	
Cer	 (20:1/18:0)	 M-H	 4.84E+05	 640.5522	
Cer	 (14:0/18:0)	 M-H	 8.28E+04	 542.479	
Cer	 (16:0/26:0)	 M-H	 8.81E+04	 650.6457	
Cer	 (20:0/26:0)	 M-H	 4.52E+04	 706.7083	
Cer	 (18:1/18:0)	 M-H	 2.54E+04	 564.5361	
Cer	 (18:1/4:0)	 M-H	 3.86E+04	 384.3119	
Cer	 (16:0/12:0)	 M-H	 8.39E+04	 454.4266	
Cer	 (18:0/26:1)	 M-H	 5.44E+04	 692.6562	
Table 45.	Lipid species of ceramide identified by the developed LC-MS/MS method. The lipid species 
represented here are from 7 growth time points (DME, D0, D1, D2, D4, D6, D8). Legend: DME stands for 
day mid-exponential phase. D stands for day and numeric values represent days of growth. The highlighted 
in yellow row is for the lipid standard of ceramide. 
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Lipid Class	 Fatty Acid Moieties	 Ionization 
Type	
MS Peak Area	 Calculated m/z 
Values	
CL	 (14:0/14:0/14:0/14:0)	 M-H	 2.18E+07	 1239.84	
CL	 (14:0/14:0/14:0/12:0)	 M-H	 5.92E+05	 1211.808	
CL	 (10:0/16:1/16:1/16:1)	 M-H	 7.58E+04	 1261.824	
CL	 (12:0/18:1/12:0/16:1)	 M-H	 5.34E+04	 1263.84	
CL	 (12:0/16:1/16:1/16:1)	 M-H	 3.33E+05	 1289.855	
CL	 (16:1/16:1/16:0/12:0)	 M-H	 2.07E+05	 1291.871	
CL	 (18:1/16:0/12:0/14:0)	 M-H	 4.16E+04	 1293.887	
CL	 (18:1/16:1/12:0/16:1)	 M-H	 6.36E+05	 1317.887	
CL	 (12:0/16:0/18:1/16:1)	 M-H	 2.32E+05	 1319.902	
CL	 (16:1/16:1/16:1/16:1)	 M-H	 8.78E+05	 1343.902	
CL	 (12:0/18:1/16:1/18:1)	 M-H	 5.20E+05	 1345.918	
CL	 (18:1/18:1/16:0/12:0)	 M-H	 1.33E+05	 1347.934	
CL	 (16:1/16:1/18:1/16:1)	 M-H	 2.86E+06	 1371.934	
CL	 (18:1/16:0/16:1/16:1)	 M-H	 9.82E+05	 1373.949	
CL	 (16:0/16:1/18:1/16:0)	 M-H	 1.14E+05	 1375.965	
CL	 (10:0/16:0/20:0/20:1)	 M-H	 4.66E+05	 1377.981	
CL	 (18:1/16:1/16:1/18:1)	 M-H	 3.93E+06	 1399.965	
CL	 (18:1/16:1/16:0/18:1)	 M-H	 4.09E+05	 1401.981	
CL	 (18:1/16:0/16:0/18:1)	 M-H	 6.33E+04	 1403.996	
CL	 (18:1/16:1/18:1/18:1)	 M-H	 2.14E+06	 1427.996	
CL	 (18:1/18:1/16:0/18:1)	 M-H	 1.32E+05	 1430.012	
CL	 (18:1/18:1/18:1/18:1)	 M-H	 2.00E+06	 1456.028	
CL	 (22:1/18:0/14:0/18:1)	 M-H	 1.91E+05	 1460.059	
CL	 (8:0/20:0/16:0/20:0)	 M-H	 1.77E+05	 1351.965	
Table 56. Lipid species of cardiolipin identified by the developed LC-MS/MS method. The lipid species 
represented here are from 7 growth time points (DME, D0, D1, D2, D4, D6, D8). Legend: DME stands for 
day mid-exponential phase. D stands for day and numeric values represent days of growth. The highlighted 
in yellow row is for the lipid standard of cardiolipin. 
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Lipid Class	 Fatty Acid 
Moieties	
Ionization Type	 MS Peak Area	 Calculated m/z 
Values	
FA	 (19:0)	 M-H	 6.71E+07	 297.2799	
FA	 (12:0)	 M-H	 2.60E+06	 199.1704	
FA	 (16:1)	 M-H	 1.68E+07	 253.2173	
FA	 (16:0)	 M-H	 1.84E+06	 255.233	
FA	 (18:1)	 M-H	 2.98E+07	 281.2486	
FA	 (18:0)	 M-H	 7.54E+06	 283.2643	
FA	 (20:1)	 M-H	 5.83E+05	 309.2799	
FA	 (20:0)	 M-H	 2.41E+06	 311.2956	
FA	 (22:0)	 M-H	 8.20E+05	 339.3269	
FA	 (24:0)	 M-H	 1.23E+06	 367.3582	
FA	 (30:0)	 M-H	 9.86E+04	 451.4521	
FA	 (10:0)	 M-H	 6.64E+04	 171.1391	
FA	 (26:0)	 M-H	 2.65E+07	 395.3895	
Table 17. Lipid species of free fatty acid identified by the developed LC-MS/MS method. The lipid 
species represented here are from 7 growth time points (DME, D0, D1, D2, D4, D6, D8). Legend: DME 
stands for day mid-exponential phase. D stands for day and numeric values represent days of growth. 
The highlighted in yellow row is for the lipid standard of free fatty acid.	
Lipid Class	 Fatty Acid Moieties	 Ionization Type	 MS Peak Area	 Calculated m/z 
Values	
PE	 (15:0/15:0)	 M-H	 3.30E+07	 662.4766	
PE	 (16:0/10:0)	 M-H	 1.08E+05	 606.414	
PE	 (16:1/12:0)	 M-H	 1.89E+05	 632.4297	
PE	 (16:0/12:0)	 M-H	 2.62E+05	 634.4453	
PE	 (18:1/12:0)	 M-H	 9.71E+04	 660.461	
PE	 (16:1/16:1)	 M-H	 8.66E+06	 686.4766	
PE	 (16:0/16:1)	 M-H	 1.65E+07	 688.4923	
PE	 (16:1/18:1)	 M-H	 1.36E+07	 714.5079	
PE	 (18:0/16:1)	 M-H	 2.74E+06	 716.5236	
PE	 (18:1/18:1)	 M-H	 2.05E+06	 742.5392	
PE	 (18:0/18:1)	 M-H	 1.52E+06	 744.5549	
PE	 (20:1/18:1)	 M-H	 2.67E+05	 770.5705	
PE	 (20:0/18:1)	 M-H	 1.95E+05	 772.5862	
PE	 (16:1/10:0)	 M-H	 6.04E+04	 604.3984	
PE	 (16:0/16:0)	 M-H	 3.18E+05	 690.5079	
PE	 (18:0/16:0)	 M-H	 1.40E+05	 718.5392	
PE	 (18:0/18:0)	 M-H	 6.33E+04	 746.5705	
PE	 (26:0/16:1)	 M-H	 2.53E+05	 828.6488	
PE	 (26:0/18:1)	 M-H	 1.68E+05	 856.6801	
PE	 (16:1/14:1)	 M-H	 1.33E+05	 658.4453	
Table 68. Lipid species of phosphatidylethanolamine identified by the developed LC-MS/MS 
method. The lipid species represented here are from 7 growth time points (DME, D0, D1, D2, D4, D6, D8). 
	 35	
Legend: DME stands for day mid-exponential phase. D stands for day and numeric values represent days 
of growth. The highlighted in yellow row is for the lipid standard of phosphatidylethanolamine. 
	
Lipid Class	 Fatty Acid Moieties	 Ionization Type	 MS Peak Area	 Calculated m/z 
Values	
PG	 (15:0/15:0)	 M-H	 6.89E+07	 693.4712	
PG	 (16:0/16:1)	 M-H	 2.24E+05	 719.4869	
PG	 (16:0/18:1)	 M-H	 6.40E+05	 747.5182	
Table 197. Lipid species of phosphatidylglycerol identified by the developed LC-MS/MS method. 
The lipid species represented here are from 7 growth time points (DME, D0, D1, D2, D4, D6, D8). Legend: 
DME stands for day mid-exponential phase. D stands for day and numeric values represent days of 
growth. The highlighted in yellow row is for the lipid standard of phosphatidylglycerol.	
	
Lipid Class	 Fatty Acid Moieties	 Ionization Type	 MS Peak Area	 Calculated m/z 
Values	
PI	 (17:0/20:4)	 M-H	 2.94E+05	 871.5342	
PI	 (16:0/10:0)	 M-H	 4.14E+05	 725.4247	
PI	 (16:0/12:0)	 M-H	 1.21E+06	 753.456	
PI	 (16:0/14:1)	 M-H	 1.56E+05	 779.4716	
PI	 (18:0/12:0)	 M-H	 8.84E+05	 781.4873	
PI	 (16:1/16:1)	 M-H	 6.34E+05	 805.4873	
PI	 (16:0/16:1)	 M-H	 5.16E+06	 807.5029	
PI	 (16:1/18:1)	 M-H	 3.71E+05	 833.5186	
PI	 (16:0/18:1)	 M-H	 9.96E+06	 835.5342	
PI	 (18:1/18:1)	 M-H	 2.64E+05	 861.5499	
PI	 (18:0/18:1)	 M-H	 4.96E+06	 863.5655	
PI	 (26:0/16:1)	 M-H	 2.19E+05	 947.6594	
PI	 (26:0/18:1)	 M-H	 1.98E+05	 975.6907	
PI	 (27:0/16:1)	 M-H	 4.68E+04	 961.6751	
Table 80. Lipid species of phosphatidylinositol identified by the developed LC-MS/MS method. The 
lipid species represented here are from 7 growth time points (DME, D0, D1, D2, D4, D6, D8). Legend: 
DME stands for day mid-exponential phase. D stands for day and numeric values represent days of 
growth. The highlighted in yellow row is for the lipid standard of phosphatidylinositol.	
	
Lipid Class	 Fatty Acid Moieties	 Ionization Type	 MS Peak Area	 Calculated m/z 
Values	
PS	 (17:0/17:0)	 M-H	 1.98E+06	 762.5291	
PS	 (16:0/16:1)	 M-H	 8.00E+05	 732.4821	
PS	 (16:1/18:1)	 M-H	 2.72E+05	 758.4978	
PS	 (16:0/18:1)	 M-H	 2.09E+06	 760.5134	
PS	 (8:0p/16:0)	 M-H	 2.94E+04	 606.3776	
Table 91. Lipid species of phosphatidylserine identified by the developed LC-MS/MS method. The 
lipid species represented here are from 7 growth time points (DME, D0, D1, D2, D4, D6, D8). Legend: DME 
stands for day mid-exponential phase. D stands for day and numeric values represent days of growth. The 
highlighted in yellow row is for the lipid standard of phosphatidylserine.	
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2.4 Results and discussion 
 
 
Like all other techniques, LC-MS/MS has its advantages and drawbacks. As we 
can see in Tables 5 and 6, although it is possible to identify all major classes of 
phospholipids using both NP-HPLC and RP-HPLC, it is impossible to achieve 100% 
ionization efficiency with either of these two columns. Overall, RP-HPLC allows to achieve 
higher ionization efficiencies than NP-HPLC (compare Tables 6 and 5, respectively). With 
both columns, the best result was obtained when mobile phase additive was ammonium 
formate in the positive mode, and ammonium acetate in the negative mode. Ionization 
efficiency is directly linked to the matrix effect in HPLC. In HPLC, the most frequent matrix 
effect is the ion suppression in which the target molecule does not get ionized to be 
detected by the first mass analyzer. Specially, the ionization efficiency is hindered when 
the ionization source is electrospray ionization, as compared to other harsher ionization 
methods such as atmospheric pressure chemical ionization (APCI). However, the 
drawback of the harsher methods of ionization is that molecular ions get fragments, so 
still the best choice of ionization is the soft ionization methods such as electrospray 
ionization [115]. More specifically ionization hindrance occurs in electrospray ionization 
when charges are added to target molecules in liquid phase where not all the target 
molecules gets charge and secondly ion suppression occurs during transformation of 
target molecules from liquid droplets to the gaseous phase [115].  
 
 The effect of all mobile phase additives is analyzed in the constant LC parameters 
such as mobile phases A and B, LC gradient, flow rate, temperature and pressure to 
prevent any error in determining the most effective additives. Our finding shows (table  6) 
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that optimal ionization is achieved in negative mode when only 10 mM of ammonium 
acetate is used as the sole additive without any kind of acid. For the positive mode, the 
result shows that optimal ionization is achieved when 10 mM of ammonium formate is 
used without any other additives. Due to difference in the chemical and physical 
properties of different lipid classes we excepted to have a random ionization efficiency of 
lipids with various additives, but it is interesting that a single additive give optimal 
ionization for almost all lipid classes that we targeted. Otherwise we had to run the sample 
with different mobile phases and with various additives to quantify the lipid classes, which 
would have been very time consuming. The values in tables 5 and 6 represents the 
average of 5 replicates run with each mobile phase additive and the percentage is relative 
to the highest peak intensity obtained in each set.  Future studies can be done with 
different dilutions of lipid standards to evaluate the ionization efficiency, since one way to 
decrease the matrix effect is to dilute the sample adequately. Also, evaluation of these 
lipid standards ionizations with the same additives can be done with shot gun lipidomics 
to compare the shot gun with LC-MS/MS. Because, sometimes it is useful to just 
determine the concentration of different classes of lipids without analysis of the structure 
of each lipid species within a specific lipid class, since direct infusion is much faster and 
easier than LC-MS/MS method. Whereas LC-MS/MS requires longer time of experiment 
and data analysis after the experiment. Also, the other drawbacks of LC-MS/MS 
technique are the loss of some target molecules by the absorption of chromatographic 
support, and the decrease of the column performance over time [119].  
 Regardless of how the lipid samples are introduced into the Mass spectrometer 
whether it is directly injected or first separated by HPLC column; it is important that the 
	 38	
lipid species should be purified from other impurities during the extraction step prior to 
introduction into mass spectrometer. The impurities in the sample are the major cause of 
matrix effect and hindrance for isobaric species identification. Some example of these 
impurities in the lipid sample are: salts, carbohydrates, amines, peptides and metabolites 
[120]. The chemically diverse nature of lipids makes it difficult to extract them from other 
impurities. In general, most impurities have hydrophilic nature, thus mostly a mixture of 
polar and nonpolar organic solvent is used for extraction of lipids.  
 
 The major types of lipid extraction solvents reported in literature are chloroform, 
dichloromethane and methyl-tert-butyl-ether (MTBE) mixed with different quantity of 
methanol [121]. Each of the extraction method has its advantages and disadvantages. 
Although it has reported that a mixture of chloroform and methanol with ratios of 17:1 first 
step and 2:1 second step of extraction can extract all classes of lipids, but this method 
has two major disadvantages. First it is very toxic and it has been classified as a probable 
human carcinogen; although exposure to normal background level or under the threshold 
level (2 ppm or 7 mg/m3) it is unlikely to result in major health problems [122]. The second 
issue with chloroform is that it has a higher density compare to water, thus lipid molecules 
together with chloroform stay in the bottom of extraction tube. Therefore, to get the lipid 
molecules the pipette tip or syringe tip must cross the insoluble layer of the extraction 
mixture. However, if even very small quantity of insoluble material is extracted together 
with lipids it can cause blockage of safe guard column, decrease the performance of 
HPLC column, and it can also clog the electrospray ionization nebulizer.  
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 Despite the drawbacks of chloroform/methanol extraction method, when we 
compared the efficiency of all these different extraction methods (tables 7, 8 and 9) the 
result (table 9) shows that highest lipid standard recovery happens when 
chloroform/methanol method was used. The values in tables 7, 8 and 9 represent the 
average of 3 replicates of lipid standard recovery from the extraction of the 3 extraction 
methods. The percentage (%) values are compared to the same concentration of lipid 
standards when injected directly into the HPLC column. The concentration determination 
is based on the mass peak area related to each lipid class. The above-mentioned 
drawbacks of chloroform/methanol extraction method can be easily minimized or 
eliminated. For instance, if the chloroform is handled with caution inside the fume hood, 
its toxic effect can be minimized to normal level. The introduction of insoluble material 
can also be minimized if a thinner glass pipette is used.  
 
 The other two extraction solvents, namely MTBE and dichloromethane, are less 
toxic than chloroform. The acceptable threshold limit for dichloromethane is 50 ppm or 
177 mg/m3 which is almost 25 time higher than the acceptable threshold limit of 
chloroform [122]. Nevertheless, dichloromethane can also be carcinogenic if continuous 
exposure is experienced [122]. MTBE on the other hand is less toxic than either of 
dichloromethane and chloroform. Also, it has lower density than water, thus during 
extraction the pipette or syringe tip doesn’t have to cross the insoluble layer, so not to 
introduce any insoluble material into the LC-MS/MS system.  
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 Nevertheless, by comparing percentage recovery of lipid standards with the three 
extraction methods examined here, the highest percentage recovery of lipid standard of 
almost all lipid classes is achieved with chloroform/methanol method of extraction table 
9. The second highest percent recovery of lipid standards is achieved with 
dichloromethane/methanol as the result shows in table 8. One of the reasons for similar 
percent recovery of lipid standards can be due to structure similarities of the two solvents, 
since dichloromethane has only one less chlorine atom than chloroform. Extraction with 
dichloromethane/methanol method can be used alternative to chloroform/methanol if the 
purpose of study is to just determine the different classes of lipids in a sample. However, 
if the purpose of study is the quantification of lipids, then the most appropriate solvent of 
extraction is chloroform/methanol method. 
 The result in table 7 shows that the least efficient extraction solvent among all 3 
extraction methods is the MTBE method. Also, the result in table 7 shows that MTBE is 
not a suitable solvent of extraction for polar lipids, because two polar lipid classes 
phosphatidylinositol, and phosphatidylserine were not extracted at all.  
 After optimizing the ionization efficiency of the precursor ion with appropriate 
modifiers (tables 5 and 6), the next important factor for analysis of different lipid classes 
depends on finding a better fragmentation method for the MS-2 analysis. The generation 
of precursor ions by electrospray ionization (ESI) is usually done by adding a proton 
[M+H]+ or a cation such as [M+Na]+ or by removing a proton [M-H]- also, other multiple-
charged ions such as [M+2H]2+ are formed by ESI ionization. Isobaric species (species 
with same molecular weight, but different in acyl chains of various lipid species) together 
with oxidized lipid class and the multiple ion formed by a single lipid species makes the 
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assignment of the MS peaks to different lipid species difficult only based on the 
precursor/parent ion. Thus, further analysis of lipid species by MS/MS is crucial for 
identification of lipid species. The two most commonly used method for fragmentation or 
activation of precursor ion are higher-energy collisional dissociation (HCD) and collisional 
induced dissociation (CID). In both fragmentation methods, the parent ions accelerate 
due to the difference in electrical potential and collides with a neutral gas (CBAMS 
Orbitrap uses nitrogen gas for fragmentation) to fragment the parent ions into small parts 
which are then detected by second mass analyzer. We have tested both methods of 
fragmentation for positive and negative modes and our findings show in tables 10 and 11 
that best result was achieved when HCD was used for positive mode and CID was used 
for negative mode. 
 
 After developing an optimized method of lipid identification and quantification, we 
successfully identified 10 different lipid classes in wild-type strain of Saccharomyces 
cerevisiae (see Tables 12 to 21). The lysoforms of some lipid classes were also detected, 
but we do not report them here because we did not have the appropriate internal 
standards to quantify them and, thus, we did not consider these molecules for further 
studies. The lipid species in each lipid class are sum of all unique species found when 
sample from growth points day mid-exponential (DME), days 0, 1, 2, 4, 6 and 8 were 
analyzed with our developed LC-MS/MS method. The reason that we collected all the 
unique species from various time points is that yeast cells make different lipid species as 
they age [86].  
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 The fatty acid moieties of majority of lipid species identified in each class are about 
16 to 18 carbons long and have even number of carbon. Most of species in each class 
identified with our method have already been reported separately when different studies 
target a subset of these lipid classes [123]. Our finding that the identified fatty acid 
moieties have even number of carbon is in parallel with previous studies [ 123]. The 
reason for this is that eukaryotes do not have odd number of carbon length in their fatty 
acid moieties [123].  
 
 The calculated mass over charge ratio (m/z) values reported in table numbers 12 
through 21 are 4 digits after the decimal point. The precision in these values is due to the 
sensitivity of the LC-MS/MS developed. Two lipid species with same molecular weight 
can be unambiguously identified if they are different in their structure. The two otherwise 
isobaric species phosphatidylcholine (PC) table 12 and ceramide (CER) table 15 both 
having the same m/z value of 650 are well separated and characterized by this optimized 
method. 
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3.0 LC-MS/MS analysis of cellular lipidomes of wild-type and various mutant 
strains of Saccharomyces cerevisiae impaired in lipid metabolism cultured 
in the presence or absence of a longevity-extending plant extract 21  
3.1 Introduction. 
  3.1-1  Background information on plant extract 21 
The Titorenko lab has recently discovered six plant extracts that delay yeast 
chronological aging and extend the chronological lifespan of Saccharomyces 
cerevisiae [66]. These 6 plant extracts have the most potent life extending 
properties yet described. Among these 6 plant extracts the most potent life 
extending plant extract is plant extract 21 (PE21) [66]. This natural compound 
(PE21) is extracted from the bark of white willow, Salix alba. PE21 acts a 
geroprotector that decreases the rate at which yeast chronologically ages and 
extends the maximum chronological lifespan of yeast under non-caloric restriction 
conditions. PE21 slows yeast chronological aging because it attenuates Sch9, a 
protein kinase that is stimulated by both the nutrient-sensing TORC1 (target of 
rapamycin complex 1) signaling pathway and the sphingolipid-dependent Pkh1/2 
(Pkb-activating kinase homolog) signaling pathway [66]. This natural compound 
achieves its geroprotector effect by 1) increasing mitochondrial respiration and 
membrane potential; 2) altering the intracellular concentrations of reactive oxygen 
species (ROS); 3) decreasing oxidative damage to cellular proteins, membrane 
lipids, and mitochondrial and nuclear genomes; 4) enhancing cell resistance to 
oxidative and thermal stresses; and 5) accelerating degradation of neutral lipids 
deposited in lipid droplets (LDs) [67]. These neutral and nonpolar lipids are steryl 
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esters and triacylglycerols are initially formed in the endoplasmic reticulum and 
then they are transported and stored in lipid droplets. These lipids are very 
hydrophobic and are prone to lipolytic degradation to generate metabolites 
required in the biosynthetic pathways of sphingolipids and phospholipids. New 
research highly suggests that the synthesis, the storage and the degradation of 
uncharged lipids are implicated in longevity extending processes [67]. 
 Recent studies in the Titorenko lab have suggested that some pathways in lipid 
metabolism is altered when yeast cells are grown with this plant extract 21. The effect of 
plant extract 21 was analyzed on the lipidome of wilt type and various mutants related to 
lipid metabolism of Saccharomyces cerevisiae by determining the alternation of lipid 
composition by the developed LC-MS/MS method. Detailed information about possible 
lipid metabolism pathways effected by plant extract #21 and the related mutants is given 
in section 3.1-2 below.  
 
3.1-2 Lipid metabolism pathways and various mutant strains of 
Saccharomyces cerevisiae impaired in these pathways 
In the complex network of lipid metabolism of saccharomyces cerevisae, 
Phosphatidic acid (PA) serves as a common precursor to most of the other lipids [86]. PA 
is produced from glycerol-3-P through an intermediate lyso form of PA using two fatty acyl 
CoA reactions. These reactions are catalyzed in the endoplasmic reticulum by the GTP2- 
and SCT1-dependent glycerol-3-P acyltransferases. Lysoform of PA to PA conversion 
involves the catalysis of SLC1 and ALE1 acyltransferases as indicated in figure 3. 
Dihydroxyacetone-P is also used as substrate by glycerol-3-P acyltransferase, then the 
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product formed is converted to PA by AYR1 reductase from lipid droplets and AYR1 
reductase from ER [86]. 
 
Figure 3. Lipid metabolism and inter-organelle transport in mitochondria, the endoplasmic 
reticulum (ER), lipid droplets (LD) and peroxisomes of the yeast S. cerevisiae. The arrows indicate 
the conversion of one lipid class to another lipid class and the enzyme(s) involve in the such pathways are 
indicated on top of the arrow. The letter P after each gene name indicates that it is the protein (enzyme) of 
that gene [69].  
 
Phosphatidic acid (PA) is converted into the different lipid classes via two routes: CDP-
DAG and DAG branches of this network as indicated in figure 3. The first subroutine, 
CDP-DAG, serves in the synthesis of all the phospholipids. PA is converted into CDP-
DAG which then metabolized in the endoplasmic reticulum to produce PI and PS or in the 
mitochondria to produce PG and then CL [75-77]. This phosphatidylserine can then be 
shuttled to the mitochondria where it serves as an intermediate in the synthesis of PE. 
The latter is then converted into PC in the endoplasmic reticulum. The second subroutine, 
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DAG, serves in the synthesis of triacylglycerols and steryl esters. In this route, PA is 
converted to DAG in the endoplasmic reticulum followed by its conversion into TAG and 
SE. These neutral lipids are then shuttled by vesicles into lipid droplets where they are 
stored for future breakdown and replenishment of the PA, DAG and FFA pools [25-27]. 
 
Few enzymes and proteins of interest are involved in this complex network.  Free 
fatty acids are converted into FFA-CoAs by two enzymes Faa1p and Faa4p [75, 77]. 
These FAA-CoA are then incorporated into phosphatidic acid by either Ale1p or Slc1p 
[75, 77]. The production of CL requires the shuttling of PA from the endoplasmic reticulum 
into the mitochondrial membrane. This lipid trafficking step occurs through Ups1p which 
associates with Mdm35 to form the shuttling complex [87]. The methylation of 
phosphatidylethanolamine to produce phosphatidylcholine in the endoplasmic reticulum 
is catalyzed by Cho2p [88]. Triacylglycerols are formed from diacylglycerols by an 
acylation step either with a transfer of acyl-CoA or acyl groups from glycerophospholipids. 
This reaction is catalyzed by either Dga1p, Are1p or Are2p. Tgl1p serves in the 
breakdown of ergosteryl esters within the plasma membrane or within lipid droplets [89 - 
91]. Tgl1p as well as Tgl3p, Tgl4p, Tgl5p are lipases that are involved in the conversion 
of triacylglycerols into free fatty acids in lipid droplets [93 – 95]. Taz1p converts CL to 
MLCL through a transacylation step in the inner mitochondrial membrane [96].  
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3.2 Materials and Methods  
3.2-1 Yeast strains 
The wild-type strain Saccharomyces cerevisiae BY4742 (MATa his3D1 leu2D0 
lys2D0 ura3D0). Mutant strains: SLC1 (MATα SUC2 gal2 mal2 mel flo1 flo8-1 hap1 ho 
bio1 bio6), TGL3 (BY4741; Mat a; his3Δ1; leu2Δ0; met15Δ0; ura3Δ0; tgl3Δ 
YMR313c::kanMX4), TGL1 (BY4741; Mat a; his3Δ1; leu2Δ0; met15Δ0; ura3Δ0; tgl1Δ 
YMR313c::kanMX4) TGL4 (BY4742; Mat α; his3Δ1; leu2Δ0; lys2Δ0; ura3Δ0; tgl4Δ 
YKR089c::kanMX4), TGL5 (BY4742; Mat α; his3Δ1; leu2Δ0; lys2Δ0; ura3Δ0; tgl5Δ 
YOR081c::kanMX4), DGA1 (MATα SUC2 gal2 mal2 mel flo1 flo8-1 hap1 ho bio1 bio6; 
DGA1Δ), ARE2 (BY4742; Mat α; his3Δ1; leu2Δ0; lys2Δ0; ura3Δ0; are2Δ 
YKR089c::kanMX4), CRD1 (BY4742; Mat α; his3Δ1; leu2Δ0; lys2Δ0; ura3Δ0; crd1Δ 
YKR089c::kanMX4), UPS1 (BY4742; Mat α; his3Δ1; leu2Δ0; lys2Δ0; ura3Δ0; ups1Δ 
YKR089c::kanMX4), TAZ1 (BY4742; Mat α; his3Δ1; leu2Δ0; lys2Δ0; ura3Δ0; taz1Δ 
YKR089c::kanMX4), CHO2 (BY4742; Mat α; his3Δ1; leu2Δ0; lys2Δ0; ura3Δ0; cho2Δ 
YKR089c::kanMX4). All these strains were bought from Thermo Scientific/Open 
Biosystems. 
3.2-2 Media and growth conditions 
Both the wild type and various mutant strains were grown in a synthetic minimal YNB 
medium (0.67% Yeast Nitrogen Base without amino acids) initially containing 2% glucose 
and supplemented with 20 mg/l histidine, 30 mg/l leucine, 30 mg/l lysine and 20 mg/l 
uracil. Cells were cultured at 30 oC with rotational shaking at 200 rpm in Erlenmeyer 
flasks at a “flask volume/medium volume” ratio of 5:1. The stock solution of aging-delaying 
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plant extract 21 (PE21) in ethanol was made on the day of adding this PE to cell cultures. 
This stock solution was added to growth medium immediately following cell inoculation 
into the medium. The final concentration of PE21 in growth medium was 0.1% (0.25 ml 
of 20% stock solution of PE21 per flask). The 20% PE21 stock solution was made by 
adding 2.5 grams of PE21 in 12.5 ml ethanol. The same condition was used for the control 
flasks, but instead of adding 0.25 ml of 20% stock solution of PE21 0.25 ml of 100% 
ethanol was added to give a percentage of 0.5% of ethanol in each flask.  
3.2-3 Cell collection and lipid extraction of Saccharomyces cerevisiae  
A hemocytometer (Hausser Scientific Catalog# 3200) was used to count yeast cells and 
to calculate the volume of cell culture containing 5.0 x 107 cells. Appropriate volume of 
cell culture was taken, and the cells were harvested by centrifugation in a Centra CL2 
clinical centrifuge at 3,000 × g for 5 min at room temperature. The cell pellet was washed 
once in ice-cold nano-pure water and once in ice-cold 155 mM ammonium bicarbonate 
(pH 8.0), and the cells were subjected to centrifugation at 16,000 × g for 1 min at 4oC. 
The cell pellet was stored at -80 oC until lipid extraction. For lipid extraction, the pelleted 
cells kept at -80 oC were thawed on ice before being re-suspended in 200 µl of ice-cold 
Nano-pure water. The re-suspended sample which contained 5 × 107 cells was 
transferred to a 15-mL high-strength glass screw top centrifuge tube with a Teflon lined 
cap (#0556912; Fisher Scientific). To each 15-mL high-strength glass tube the following 
was added: 1) 25 µL of the internal standard mix prepared in mixture of chloroform: 
methanol (both OPTIMA grade from Fisher Scientific used for LC-MS with CAS# 76-09-3 
and 67-56-1), 2) 100 μL of 425-600 μM acid-washed glass beads to break open the cells 
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(#G8772; Sigma-Aldrich) and 600 µL of chloroform : methanol at a 17:1 ratio both from 
Fisher Scientific with OPTIMA grade and CAS# 76-09-3 and 67-56-1. The samples were 
then vortexed vigorously for 5 minute at room temperature to breakdown the cells and 
subjected to centrifugation in a Centra CL2 clinical centrifuge at 3,000 × g for 5 min at 
room temperature; this centrifugation allowed to separate the upper aqueous phase from 
the lower organic phase, which contained nonpolar lipids TAG, PC, PE and PG. The lower 
organic phase (400 µL) was then transferred to another 15-mL high-strength glass screw 
top centrifuge tube using pipette with polypropylene gel loading tips (Fisher scientific 
catalog# 13-611-115) with careful attention not to disrupt the glass beads or upper 
aqueous phase. 300 µL of chloroform-methanol (2:1) solution was added to the remaining 
upper aqueous phase to allow the extraction of sphingolipids and of polar lipids PA, PS, 
PI and CL. The samples were again vortexed vigorously at room temperature for 5 
minutes. The initial separated organic band was kept at under the flow of nitrogen gas for 
the duration of the second vortexing. The samples were again centrifuged for 5 min at 
3,000 × rpm at room temperature; the lower organic phase (200 µL) was then separated 
and added to the corresponding initial organic phase with pipette using the polypropylene 
gel loading tips. With both lower organic phases combined, the solvent was evaporated 
off by nitrogen gas flow. Once all solvent was evaporated, the tubes containing the lipid 
film were closed under the flow of nitrogen gas and stored in -80oC. 
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Detection 
mode Lipid classes 
Lipid chain 
composition 
Calculated 
M/Z values 
Moles in 
samples 
Negative 
Ceramide (18:1/17:0) 550.5204675 
2.26E-09 
Cardiolipin (14:0/14:0/14:0/14:0)  1239.839755 
1.96E-09 
Free Fatty Acid 19:0 297.2799035 
8.37E-09 
phosphatidylethanolamine (15:0/15:0) 662.4766305 
3.77E-09 
Phosphatidylglycerol (15:0/15:0) 693.4712115 
3.49E-09 
phosphatidylinositol (17:0/20:4) 871.5342065 
3.00E-11 
phosphatidylserine (17:0/17:0) 762.5290605  
3.18E-09 
Positive 
phosphatidylcholine (13:0/13:0)  650.4755335 
3.85E-09 
phytosphingosine (16:1)  272.2584055 
2.25E-09 
triacylglycerol (28:1/10:1/10:1) 818.7232155 3.67E-09 
Table 102. Internal lipid standards used for the experiment. Note: Internal lipid standards CL, 
CER, PI, SO, PE, PG, FFA, PS and PC were all from Avanti Polar Lipid, Alabaster, AL, USA. TAG 
internal standard originates from Larodan, Malmo, Sweden.  
	
	
3.2-4 Sample preparation for LC-MS/MS  
500 µL of acetonitrile: 2-propanol: H2O with ratio of (65:35:5) all with LC-MS grade from 
Fisher Scientific (catalog# A9551, A4611 and W6212 ) added to tubes containing the lipid 
film. Each tube was vortexed 3 times for 10 seconds each time and then all the samples 
were sonicated for 15 minutes and vortexed again as above and 100 µL from each sample 
was added to glass vials with inserts used for Agilent1100 Wellplate (note: it is important 
to eliminate all the air bubbles in the insert before putting the vials in the Agilent1100 
Wellplate). 
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3.2-5 Liquid chromatography conditions 
The LC–MS experiments were performed using an Agilent 1100 series LC system 
(Agilent Technologies) equipped with a binary pump, de-gaser and an autosamples. Lipid 
species were separated on a reverse-phase column CSH C18 (2.1 mm; 75 mm; pore size 
130 Å; pH range of 1-11) (Waters, Milford, MA, USA) coupled to a CSH C18 VanGuard 
(Waters). The column was maintained at 55 °C at a flow-rate of 0.3 mL/min. The mobile 
phases consisted of (A) 60:40 (v/v) acetonitrile: water and (B) 90:10 (v/v) isopropanol: 
acetonitrile. For the positive mode ESI (+) both mobile phases A and B were mixed with 
10 mM ammonium formate (0.631 g/L) from Fisher Scientific (catalog# A115-50). For the 
negative mode ESI (-) both mobile phases A and B were mixed with 10 mM ammonium 
acetate (0.771 g/L) from Fisher Scientific (catalog# 631-61-8). To enhance solubilizing of 
ammonium formate and ammonium acetate both salts were dissolved first in small 
volume of water (50 µl) before their addition in the mobile phases. Each mobile phase 
with modifiers (ammonium formate and ammonium acetate) was mixed, sonicated for 20 
minutes to achieve complete dissolving of modifiers, mixed again, and then sonicated for 
another 20 minutes. 
The separation of different lipid species by HPLC was achieved under the following 
HPLC gradient: 0 to 4 min 90%(A); 4 to 10 min 40%(A); 10 to 21 min 32% (A); 21 to 24 
min 3 % (A); 24 to 33 min 90 % (A). A sample volume of 5 µl and 10 µl was used for the 
injection in ESI (+) and ESI (-) respectively. Samples were kept in the Agilent1100 
Wellplate. 
3.2-6 Mass spectrometry 
Extracted lipids were separated by HPLC and analyzed with Thermo Orbitrap Velos Mass 
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Spectrometer equipped with ESI ion source (Thermo Scientific). Parent ions (MS-1) were 
detected in positive and negative modes using the FT analyzer at a resolution of 60,000. 
The MS-1 mass range used is from 150 – 2000 Dalton.  
 
Ion Source type ESI 
Capillary Temperature oC 300 
Source heater Temperature oC 300 
Sheath Gas Flow 10 
Aux Gas flow 5 
Table 113. Thermo Orbitrap Velos mass spectrometer’s tune file instrument settings. Legend: ESI 
stands for electrospray ionization.  
 
Instrument polarity Positive Negative 
Activation type HCD CID 
Min. signal required 5000 5000 
Isolation Width 2.0 2.0 
Normalized Collision energy 55.0 35 
Default charge state 2 2 
Activation time 0.1 10 
Table 124. Instrument method for MS-2 used in this experiment. Legend: HCD stands for High-
energy-induced-collision-dissociation, and CID stands for collision-induced-dissociation.  
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3.2-7 Processing of raw data from LC-MS 
Raw files from LC-MS were analyzed by Lipid Search software (V4.1) from Thermo 
Fisher. The Lipid Identification Software “Lipid Search” was used to identify different lipid 
classes with the help of Molecular Fragmentation Query Language based on the below 
(Table 4) parameters. In addition to the parameters below (Table 4) an extra manual filter 
was applied to eliminate any Fatty Acid with odd number of carbon and to eliminate any 
fatty acid with more than 1 double bond (polyunsaturated fatty acid).  
Identification  
Database Orbitrap 
Peak detection Recall isotope (ON) 
Search option Product search Orbitrap 
Search type Product 
Experiment type LC-MS 
Precursor tol 10 ppm 
Product tol 
HCD (positive mode) 20 ppm 
CID (negative mode) 0.5 da 
 Quantitation  
Execute quantitation ON 
Mz tol -5.0; +5.0 
Tol type ppm 
Filter 
Top rank filter ON 
Main node filter Main isomer peak 
m-score threshold 5.0 
c-score threshold 2.0 
FFA priority ON 
ID quality filter 
A Lipid class & FA are completely identified 
B Lipid class & some FA are identified 
C Lipid class or FA are identified 
D Lipid identified by other fragment ions 
(H2O, etc) 
 Lipid Class  
HCD (positive) PC, SO, TG 
CID (negative) CER, CL, FA, PE, PG, PI, PS 
Ions 
HCD (positive) +H, +NH4, +Na 
CID (negative) -H, -2H, +HCOO 
Table 135. The parameters for lipid search software (V 4.1) used in the experiment for lipid detection. 
Legend: HCD stands for High-energy-induced-collision-dissociation, and CID stands for collision-induced-
dissociation.  
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3.3 Tables and figures of various lipid classes for wild-type cells treated with 
PE21 or remained untreated 
LIPID 
CLASS 
DME D0 D1 D2 D4 D6 D8 
PC 1.14E+00 8.78E+00 5.87E+00 5.28E-01 8.47E-01 7.54E-01 5.15E-01 
SO 7.08E+01 3.39E+01 4.11E+01 2.27E+00 2.68E+01 4.79E+01 5.71E+01 
TG 6.64E+00 1.01E+01 1.89E+01 4.65E-01 2.16E+01 2.64E+01 1.47E+01 
CER 1.90E+00 5.80E+00 4.00E+00 1.82E-01 3.81E+00 7.71E-01 4.56E+00 
CL 6.79E-01 1.44E+00 1.16E+00 6.79E-02 1.76E+00 1.25E+00 1.59E+00 
FA 4.04E+00 1.67E+01 1.02E+01 5.53E-01 6.55E+00 8.41E+00 6.46E+00 
PE 4.52E+00 6.45E+00 4.69E+00 8.68E+01 5.16E+00 2.44E+00 2.78E+00 
PG 2.23E-02 4.55E-01 2.83E-01 1.41E-02 4.97E-02 1.94E-02 6.43E-03 
PI 1.30E+00 3.84E+00 1.96E+00 7.90E-02 6.61E-01 4.31E-01 5.57E-01 
PS 2.72E+00 5.62E+00 5.18E+00 5.17E-01 2.49E+01 3.97E+00 8.95E+00 
Table 146. Mean percentage value of wild type control lipid species identified by developed LC-
MS/MS method.  The values are the mean (% of whole lipidome) of two experiments for the wild type strain 
taken at 7 time points (DME, D0, D1, D2, D4, D6, D8). The mean (%) values are shown in figures 4-13. 
Legend: DME stands for day mid-exponential. D stands for day and numeric values represent days of 
growth. Lipid class: Phosphatidylcholine, sphingosine, Triacylglycerol, Ceramide, Cardiolipin, Free Fatty 
Acid, Phosphatidylethanolamine, Phosphatidylglycerol, Phosphatidylinositol, Phosphatidylserine. 
LIPID 
CLASS 
DME D0 D1 D2 D4 D6 D8 
PC 0.0505935 0.4535511 0.2582072 0.2449733 0.0637053 0.129691737 0.2110605 
SO 3.4121109 1.863243 2.4070247 0.1772678 1.849794 3.119837559 3.7796413 
TG 0.3252402 0.6886521 1.203741 0.034841 1.5112929 1.418779605 1.7323119 
CER 0.0440361 0.2210655 0.1673791 0.008917 0.1361826 0.037539913 0.1824743 
CL 0.0421655 0.0752303 0.0597828 0.0037301 0.1165151 0.057574775 0.0358539 
FA 0.2574151 1.1103996 0.7549778 0.0495599 0.5000848 0.681187833 0.2913811 
PE 0.1757019 0.1895866 0.173524 6.0007662 0.2023507 0.066542081 0.9180897 
PG 0.0013712 0.0198524 0.0145072 0.001113 0.003684 0.000961483 0.0045493 
PI 0.0569928 0.1625117 0.073704 0.0041955 0.0373794 0.010241971 0.1437976 
PS 0.0645074 0.1489661 0.1346236 0.0235393 1.2171991 0.162474513 2.3065374 
Table 27. Standard deviation of wild type control lipid species identified by developed LC-MS/MS 
method. The values are calculated as the sample standard deviation (±%) of two experiments for the wild 
type strain taken at 7 time points (DME, D0, D1, D2, D4, D6, D8). Sample standard deviation was used 
because the sample is biological. These standard deviations are represented as error bars in figures 4-13. 
Legend: DME stands for day mid-exponential. D stands for day and numeric values represent days of 
growth. Lipid class: Phosphatidylcholine, Sphingosine, Triacylglycerol, Ceramide, Cardiolipin, Free Fatty 
Acid, Phosphatidylethanolamine, Phosphatidylglycerol, Phosphatidylinositol, Phosphatidylserine. 
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LIPID 
CLASS 
DME D0 D1 D2 D4 D6 D8 
PC 1.81E+00 3.90E+00 3.26E+00 3.43E+00 1.87E+00 1.02E+00 7.85E-01 
SO 6.71E+01 5.36E+01 3.21E+01 3.43E+01 3.33E+01 3.83E+01 5.58E+01 
TG 2.03E+01 1.98E+01 2.67E+01 2.51E+01 7.80E+00 1.78E+01 1.25E+01 
CER 2.94E+00 4.05E+00 4.36E+00 3.73E+00 2.09E+00 2.79E+00 3.11E+00 
CL 1.93E-01 5.38E-01 5.41E-01 5.05E-01 5.53E-01 7.06E-01 6.11E-01 
FA 1.32E+00 1.07E+00 1.46E+00 1.60E+00 6.40E-01 5.46E-01 9.93E-01 
PE 5.49E+00 6.57E+00 1.07E+01 8.04E+00 6.70E+00 5.66E+00 3.96E+00 
PG 1.10E-02 6.37E-02 2.03E-01 8.44E-02 6.23E-02 3.10E-02 0.00E+00 
PI 2.38E+00 2.20E+00 3.57E+00 2.26E+00 1.34E+00 8.99E-01 7.90E-01 
PS 1.37E+00 4.24E-01 9.75E+00 1.46E+01 4.20E+01 2.81E+01 1.50E+01 
Table 28. Mean percentage value of wild type treated with PE21 lipid species identified by developed 
LC-MS/MS method. The values are the mean (% of whole lipidome) of two experiments for the wild type 
strain treated with PE21 taken at 7 time points (DME, D0, D1, D2, D4, D6, D8). The mean (%) values are 
shown in figures 4-13. Legend: DME stands for day mid-exponential. D stands for day and numeric values 
represent days of growth. Lipid class: Phosphatidylcholine, Sphingosine, Triacylglycerol, Ceramide, 
Cardiolipin, Free Fatty Acid, Phosphatidylethanolamine, Phosphatidylglycerol, Phosphatidylinositol, 
Phosphatidylserine. 
LIPID 
CLASS 
DME D0 D1 D2 D4 D6 D8 
PC 1.81E+00 3.90E+00 3.26E+00 3.43E+00 1.87E+00 1.02E+00 7.85E-01 
SO 6.71E+01 5.36E+01 3.21E+01 3.43E+01 3.33E+01 3.83E+01 5.58E+01 
TG 2.03E+01 1.98E+01 2.67E+01 2.51E+01 7.80E+00 1.78E+01 1.25E+01 
CER 2.94E+00 4.05E+00 4.36E+00 3.73E+00 2.09E+00 2.79E+00 3.11E+00 
CL 1.93E-01 5.38E-01 5.41E-01 5.05E-01 5.53E-01 7.06E-01 6.11E-01 
FA 1.32E+00 1.07E+00 1.46E+00 1.60E+00 6.40E-01 5.46E-01 9.93E-01 
PE 5.49E+00 6.57E+00 1.07E+01 8.04E+00 6.70E+00 5.66E+00 3.96E+00 
PG 1.10E-02 6.37E-02 2.03E-01 8.44E-02 6.23E-02 3.10E-02 0.00E+00 
PI 2.38E+00 2.20E+00 3.57E+00 2.26E+00 1.34E+00 8.99E-01 7.90E-01 
PS 1.37E+00 4.24E-01 9.75E+00 1.46E+01 4.20E+01 2.81E+01 1.50E+01 
Table 29. Standard deviation of wild type treated with PE21 lipid species identified by developed 
LC-MS/MS method. The values are calculated as the sample standard deviation (±%) of two experiments 
for the wild type strain treated with PE21 taken at 7 time points (DME, D0, D1, D2, D4, D6, D8). Sample 
standard deviation was used because the sample is biological. These standard deviations are represented 
as error bars in figures 4-13.  Legend: DME stands for day mid-exponential. D stands for day and numeric 
values represent days of growth. Lipid class: Phosphatidylcholine, Sphingosine, Triacylglycerol, Ceramide, 
Cardiolipin, Free Fatty Acid, Phosphatidylethanolamine, Phosphatidylglycerol, Phosphatidylinositol, 
Phosphatidylserine. 
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Figure 4. Mean percentage values of Phosphatidylcholine relative to the whole lipidome for wild-
type control compared to wild-type treated with PE21, as measured by the developed LC-MS/MS 
method at 7 time points. Error bars presented are from Table 2 and Table 4. For growth conditions of 
control and treated with 21 refer to Materials and Methods in chapter 3 Legend: DME stands for day mid-
exponential. D stands for day and numeric values represent days of growth. PE21 stands for plant extract 
21. 
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Figure 5. Mean percentage values of Sphingosine relative to the whole lipidome for wild-type control 
compared to wild-type treated with PE21, as measured by the developed LC-MS/MS method at 7 
time points. Error bars presented are from Table 2 and Table 4. For growth conditions of control and 
treated with 21 refer to Materials and Methods in chapter 3 Legend: DME stands for day mid-exponential. 
D stands for day and numeric values represent days of growth. PE21 stands for plant extract 21. 
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Figure 6. Mean percentage values of Triacylglycerol relative to the whole lipidome for wild-type 
control compared to wild-type treated with PE21, as meassured by the developed LC-MS/MS method 
at 7 time points. Error bars presented are from Table 2 and Table 4. For growth conditions of control and 
treated with 21 refer to Materials and Methods in chapter 3. Legend: DME stands for day mid-exponential. 
D stands for day and numeric values represent days of growth. PE21 stands for plant extract 21. 
	
Figure 7. Mean percentage values of Ceramide relative to the whole lipidome for wild-type control 
compared to wild-type treated with PE21, as measured by the developed LC-MS/MS method at 7 
time points. Error bars presented are from Table 2 and Table 4. For growth conditions of control and 
treated with 21 refer to Materials and Methods in chapter 3 Legend: DME stands for day mid-exponential. 
D stands for day and numeric values represent days of growth. PE21 stands for plant extract 21. 
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Figure 8. Mean percentage values of Cardiolipin relative to the whole lipidome for wild-type control 
compared to wild-type treated with PE21, as measured by the developed LC-MS/MS method at 7 
time points. Error bars presented are from Table 2 and Table 4. For growth conditions of control and 
treated with 21 refer to Materials and Methods in chapter 3 Legend: DME stands for day mid-exponential. 
D stands for day and numeric values represent days of growth. PE21 stands for plant extract 21. 
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Figure 9. Mean percentage values of Free Fatty Acid relative to the whole lipidome for wild-type 
control compared to wild-type treated with PE21, as measured by the developed LC-MS/MS method 
at 7 time points. Error bars presented are from Table 2 and Table 4. For growth conditions of control and 
treated with 21 refer to Materials and Methods in chapter 3 Legend: DME stands for day mid-exponential. 
D stands for day and numeric values represent days of growth. PE21 stands for plant extract 21. 
	
Figure 10. Mean percentage values of Phosphatidylethanolamine relative to the whole lipidome for 
wild-type control compared to wild-type treated with PE21, as measured by the developed LC-
MS/MS method at 7 time points. Error bars presented are from Table 2 and Table 4. For growth conditions 
of control and treated with 21 refer to Materials and Methods in chapter 3 Legend: DME stands for day mid-
exponential. D stands for day and numeric values represent days of growth. PE21 stands for plant extract 
21. 
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Figure 11. Mean percentage values of Phosphatidylglycerol relative to the whole lipidome for wild-
type control compared to wild-type treated with PE21, as measured by the developed LC-MS/MS 
method at 7 time points. Error bars presented are from Table 2 and Table 4. For growth conditions of 
control and treated with 21 refer to Materials and Methods in chapter 3 Legend: DME stands for day mid-
exponential. D stands for day and numeric values represent days of growth. PE21 stands for plant extract 
21. 
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Figure 12. Mean percentage values of Phosphatidylinositol relative to the whole lipidome for wild-
type control compared to wild-type treated with PE21, as measured by the developed LC-MS/MS 
method at 7 time points. Error bars presented are from Table 2 and Table 4. For growth conditions of 
control and treated with 21 refer to Materials and Methods in chapter 3 Legend: DME stands for day mid-
exponential. D stands for day and numeric values represent days of growth. PE21 stands for plant extract 
21. 
	
Figure 13. Mean percentage values of Triacylglycerol relative to the whole lipidome for wild-type 
control compared to wild-type treated with PE21, as measured by the developed LC-MS/MS method 
at 7 time points. Error bars presented are from Table 2 and Table 4. For growth conditions of control and 
treated with 21 refer to Materials and Methods in chapter 3 Legend: DME stands for day mid-exponential. 
D stands for day and numeric values represent days of growth. PE21 stands for plant extract 21. 
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3.3-1 Results and discussion of section 3.3.  
Using the optimized LC-MS/MS method developed in Chapter 2 of this thesis, the 
effects of plant extract 21 on the lipidome of Saccharomyces cerevisiae is analyzed in 
this chapter. The findings of the study show that plant extract 21 considerably remodels 
the lipidome of Saccharomyces cerevisiae, thus the action of PE 21 should involve some 
aspects of the lipid metabolism pathways. Lipid metabolism pathways and inter-organelle 
transport in mitochondria, the endoplasmic reticulum (ER), lipid droplets (LD) and 
peroxisomes of the yeast S. cerevisiae involve numerous steps, each catalyzed by a 
known enzyme or several enzymes as it is illustrated in Figure 3. 
The result in Figure 4 shows that PE21 increases the concentration of 
phosphatidylcholine (PC) late in life of chronologically aging yeast. PE 21 is involved in 
at least two different pathways to increase PC concentration in yeast when treated with 
PE21. These pathways are shown in Figure 3 as follows: 1) an increase of Cho2p and/or 
Opi3p concentration/activity; or 2) a decrease of Taz1p concentration/activity.  Current 
studies in the Titorenko lab are addressing a hypothesis that the late-in-life increase of 
PC concentration plays an essential role in aging delay by PE21. These studies are aimed 
at answering the following 3 questions: 1) Will a mutation eliminating one of the enzymes 
involved in PC synthesis (such as Cho2p or Opi3p; Figure 3) impair the aging-delaying 
effect of PE21? 2) Will a mutation eliminating the enzyme involved in PC consumption 
(such as Taz1p; Figure 3) enhance the aging-delaying effect of PE21? 3) What are the 
concentrations of PC and other lipid classes in cells of each of these mutant strains? 
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 Figures 5 and 7 shows that PE21 has a random effect on the concentration of 
sphingosine and ceramide lipid classes of yeast. Unlike other lipid classes, there is no an 
obvious trend of increasing or decreasing concentration of these two lipid classes as 
yeast cells age chronologically. Therefore, to conclude anything about possible role of 
PE21 on the remodeling of these two lipid classes more studies must be carried out on 
the mutant strains related to metabolism of these two lipid classes.  
 
 The result in Figure 6 shows that PE21 decreases the concentration of the neutral 
lipid triacylglycerol (TAG) in chronologically aging yeast. There are three possible ways 
of decreasing the concentration of TAG in yeast treated with PE21 (Figure 3). These 
different ways are as follows: 1) a decrease in the concentration/activity of enzymes 
Are1p and/or Are2p, 2) a decrease in the concentration/activity of enzymes Dga1p and/or 
Are2p or 3) an increase in the concentration/activity of enzymes Tgl1p, Tgl3p, Tgl4p 
and/or Tgl5p (Figure 3). Current studies in the Titorenko lab on various yeast mutant 
strains impaired in lipid metabolism are addressing the importance of the observed 
decreased TAG concentration in the aging-delaying ability of PE21 by answering the 
following 3 questions: 1) Will a mutation eliminating Are1p, Are2p, Dga1p or Lro1p 
enhance the aging-delaying effect of PE21? 2) Will a mutation eliminating Tgl1p, Tgl3p, 
Tgl4p or Tgl5p impair the aging-delaying effect of PE21? 3) What will be the 
concentrations of TAG and other lipid classes in cells of each of these mutant strains? 
 
 The result in Figure 8 shows that PE21 decreases the concentration of cardiolipin 
in the chronologically aging yeast. CL concentration can be decreased in yeast treated 
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with PE21 through a decrease in the concentration or activity of any of the following 
enzymes (Figure 1): Ups1p, Tam41p, Pgs1p, Gep4p, Crd1p, Cld1p or Taz1p. Current 
studies in the Titorenko lab on various yeast mutant strains impaired in lipid metabolism 
are addressing the importance of the early-in-life decreased CL concentration in the 
aging-delaying ability of PE21 by answering the following 2 questions: 1) Will  a mutation 
eliminating an enzyme involved in CL synthesis (such as Ups1p, Tam41p, Pgs1p, Gep4p, 
Crd1p, Cld1p or Taz1p) enhance the aging-delaying effect of PE21? 2) What would be 
the concentrations of CL and other lipid classes in cells of each of these mutant strains? 
 
 Figure 9 shows that PE21 markedly decreases the concentration of free fatty acids. 
Since the concentration of TAG is also decreased by PE21, we can exclude the effect of 
PE21 on the enzymes Tg1p, Tg3p, Tg4p and Tg5p (all of which reside in lipid droplets). 
Most likely, PE21 directs the conversion of free fatty acids into different classes of 
phospholipids such as PE, PC, PI, PS and PG. Indeed, the results show that PE21 
increases the concentration of these lipid classes. To further investigate a possible 
mechanism through which PE21 decreases the concentration of free fatty acids, many 
mutant strains impaired in the metabolism of free fatty acids are currently investigated in 
the Titorenko lab.  
 
 The result in Figure 10 shows that PE21 increases the concentration of 
phosphatidylethanolamine (PE) in chronologically aging yeast. PE21 can increase the 
concentration of PE in two different ways (Figure 1). The ways include the following: 1) 
an increase in the concentration or activity of Psd1p or 2) a decrease in the concentration 
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or activity of Cho2p and/or Opi3p. Current studies in the Titorenko lab on various yeast 
mutant strains impaired in lipid metabolism are addressing the importance of the 
observed increased PE concentration in the aging-delaying ability of PE21 by answering 
the following 3 questions: 1) Will a mutation eliminating an enzyme involved in PE 
synthesis (such as Psd1p) eliminate the aging-delaying effect of PE21? 2) Will a mutation 
eliminating an enzyme involved in PE consumption (such as Cho2p or Opi3p) enhance 
the aging-delaying effect of PE21? 3) What would be the concentrations of PE and other 
lipid classes in cells of each of these mutant strains? 
 The result in Figure 11 shows that PE21 does not have consistent effect on the 
concentrations of phosphatidylglycerol (PG), ceramides and sphingosine (Figures 5 and 
7). To further narrow down the effect of PE21 on the concentration of PG, more studies 
need be done on mutant strains impaired in PG metabolism in Saccharomyces 
cerevisiae.  
 The result in Figure 12 shows that PE21 increases the concentration of 
phosphatidylinositol (PI). PE21 can only increase the concentration of PI by increasing 
the concentration and/or activity of Cds1p and/or Pis1p (Figure 3). Current studies in the 
Titorenko lab on various yeast mutant strains impaired in lipid metabolism are addressing 
the importance of the PE21-dependent increase of PI by answering the following 2 
questions: 1) Will  mutations eliminating enzymes involved in PI synthesis (such as Cds1p 
or Pis1p) eliminate the aging-delaying effect of PE21? 2) What will be the concentrations 
of PI and other lipid classes in cells of each of these mutant strains? 
 Figure 13 shows that PE21 increases the concentration of phosphatidylserine (PS) 
in chronologically aging yeast. PE21 can increase PS concentration in two different ways. 
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These two ways are as follows: 1) an increase in the concentration or activity of Cds1p 
and/or Cho1p or 2) a decrease in the concentration or activity of Psd1p (Figure 3). Current 
studies in the Titorenko lab on various yeast mutant strains impaired in lipid metabolism 
are addressing the importance of the PE21-dependent increase in PS concentration by 
answering the following three questions: 1) Will mutations eliminating enzymes involved 
in PS synthesis (such as Cds1p or Cho1p) eliminate the aging-delaying effect of PE21? 
2) Will a mutation eliminating Psd1p, an enzyme involved in PS consumption, enhance 
the aging-delaying effect of PE21? 3) What would be the concentrations of PS and other 
lipid classes in cells of each of these mutant strains? 
 In sum, our findings indicate that PE21 remodels the lipid composition of wild-type 
Saccharomyces cerevisiae. Specifically, PE21 increases the concentration of PI, PS, PG, 
PC and PE. Because PA is the precursor for all phospholipids, PE21 is likely to somehow 
intensify the flow of PA into the endoplasmic reticulum and/or mitochondria where the 
synthesis of these lipids occurs.  
 TAG synthesis occurs in the endoplasmic reticulum, thus the observed PE21-
dependent decrease in TAG concentration suggests that PE21 may decrease the flow of 
PA into the endoplasmic reticulum. Previous studies in the Titorenko lab on a decrease 
in CL concentration have revealed that such change in CL abundance can change 
mitochondrial functionality [124]. Specifically, it has been demonstrated that a decline in 
CL concentration can stimulate mitochondrial respiration and membrane potential and 
also to decrease mitochondrial production of reactive oxygen species [124].  
 Current studies in the Titorenko lab are focused on analysis of possible 
mechanisms through which PE21 causes such remodeling of yeast lipidome. One 
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hypothesis is that PE21 may increase yeast chronological lifespan by decreasing the 
concentration of free fatty acids. Such decline in the abundance of free fatty acid may 
decrease the rate of liponecrosis, which is a programmed cell death elicited in response 
to elevated intracellular concentrations of free fatty acids. This mechanism is discussed 
in more details in Section 3.4.  
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3.4 Tables and figures of various lipid classes for wild-type and 4 mutant strains 
impaired in lipid metabolism when the cells were grown without PE21 
 
LIPID 
CLASS DME D0 D1 D2 D4 D6 D8 
PC 1.14E+00 8.78E+00 5.87E+00 5.28E-01 8.47E-01 7.54E-01 5.15E-01 
SO 7.08E+01 3.39E+01 4.11E+01 2.27E+00 2.68E+01 4.79E+01 5.71E+01 
TG 6.64E+00 1.01E+01 1.89E+01 4.65E-01 2.16E+01 2.64E+01 1.47E+01 
CER 1.90E+00 5.80E+00 4.00E+00 1.82E-01 3.81E+00 7.71E-01 4.56E+00 
CL 6.79E-01 1.44E+00 1.16E+00 6.79E-02 1.76E+00 1.25E+00 1.59E+00 
FA 4.04E+00 1.67E+01 1.02E+01 5.53E-01 6.55E+00 8.41E+00 6.46E+00 
PE 4.52E+00 6.45E+00 4.69E+00 8.68E+01 5.16E+00 2.44E+00 2.78E+00 
PG 2.23E-02 4.55E-01 2.83E-01 1.41E-02 4.97E-02 1.94E-02 6.43E-03 
PI 1.30E+00 3.84E+00 1.96E+00 7.90E-02 6.61E-01 4.31E-01 5.57E-01 
PS 2.72E+00 5.62E+00 5.18E+00 5.17E-01 2.49E+01 3.97E+00 8.95E+00 
Table 30. Mean percentage value of wild type lipid classes identified by developed LC-MS/MS 
method when grown without PE21. The values are the mean (% of whole lipidome) of two experiments 
for the wild type strain taken at 7 time points (DME, D0, D1, D2, D4, D6, D8). Legend: DME stands for day 
mid-exponential. D stands for day and numeric values represent days of growth. Lipid class: 
Phosphatidylcholine, sphingosine, Triacylglycerol, Ceramide, Cardiolipin, Free Fatty Acid, 
Phosphatidylethanolamine, Phosphatidylglycerol, Phosphatidylinositol, Phosphatidylserine. 
	
	
	
	
LIPID 
CLASS DME D0 D1 D2 D4 D6 D8 
PC 0.0505935 0.4535511 0.2582072 0.2449733 0.0637053 0.129691737 0.2110605 
SO 3.4121109 1.863243 2.4070247 0.1772678 1.849794 3.119837559 3.7796413 
TG 0.3252402 0.6886521 1.203741 0.034841 1.5112929 1.418779605 1.7323119 
CER 0.0440361 0.2210655 0.1673791 0.008917 0.1361826 0.037539913 0.1824743 
CL 0.0421655 0.0752303 0.0597828 0.0037301 0.1165151 0.057574775 0.0358539 
FA 0.2574151 1.1103996 0.7549778 0.0495599 0.5000848 0.681187833 0.2913811 
PE 0.1757019 0.1895866 0.173524 6.0007662 0.2023507 0.066542081 0.9180897 
PG 0.0013712 0.0198524 0.0145072 0.001113 0.003684 0.000961483 0.0045493 
PI 0.0569928 0.1625117 0.073704 0.0041955 0.0373794 0.010241971 0.1437976 
PS 0.0645074 0.1489661 0.1346236 0.0235393 1.2171991 0.162474513 2.3065374 
Table 31. Standard deviation of wild type lipid classes identified by developed LC-MS/MS method 
when grown without PE21. The values are calculated as the sample standard deviation (±%) of two 
experiments for the wild type strain taken at 7 time points (DME, D0, D1, D2, D4, D6, D8). Sample standard 
deviation was used because the sample is biological. Legend: DME stands for day mid-exponential. D 
stands for day and numeric values represent days of growth. Lipid class: Phosphatidylcholine, Sphingosine, 
Triacylglycerol, Ceramide, Cardiolipin, Free Fatty Acid, Phosphatidylethanolamine, Phosphatidylglycerol, 
Phosphatidylinositol, Phosphatidylserine. 
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LIPID 
CLASS DME D0 D1 D2 D4 D6 D8 
PC 3.83E-01	 2.00E+00	 7.33E-01	 1.37E+00	 7.91E-01	 2.96E-01	 6.64E-02	
SO 6.42E+01	 4.80E+01	 6.79E+01	 6.26E+01	 4.83E+01	 6.90E+01	 6.96E+01	
TG 1.14E+01 1.89E+01 4.65E-01 2.16E+01 2.64E+01 1.47E+01 1.04E+01 
CER 3.59E-01	 3.76E+00	 1.63E+00	 2.47E+00	 3.87E+00	 2.56E+00	 2.91E+00	
CL 2.25E-01	 6.68E-01	 2.88E-01	 6.31E-01	 1.02E+00	 6.55E-01	 3.41E-01	
FA 1.26E+01	 2.02E+01	 6.78E+00	 6.73E+00	 1.13E+01	 8.90E+00	 4.78E+00	
PE 7.92E-01	 1.94E+00	 5.40E-01	 8.76E-01	 1.42E+00	 7.65E-01	 3.80E-01	
PG 5.69E-03	 2.45E-02	 8.35E-03	 2.38E-02	 3.71E-02	 1.09E-02	 0.00E+00	
PI 1.43E+00	 2.12E+00	 9.73E-01	 6.76E-01	 1.06E+00	 4.03E-01	 2.54E-01	
PS 1.46E+00	 1.91E+00	 6.13E+00	 5.13E+00	 7.98E+00	 4.36E+00	 5.07E+00	
Table 152.	Mean percentage values for mutant strain 8 lipid classes identified by the developed LC-
MS/MS method in cells grown without PE21. The values are the mean (% of whole lipidome) of two 
experiments for the wild type strain taken at 7 time points (DME, D0, D1, D2, D4, D6, D8). Legend: DME 
stands for day mid-exponential. D stands for day and numeric values represent days of growth. Lipid class: 
Phosphatidylcholine, sphingosine, Triacylglycerol, Ceramide, Cardiolipin, Free Fatty Acid, 
Phosphatidylethanolamine, Phosphatidylglycerol, Phosphatidylinositol, Phosphatidylserine. Mutant strain 8 
is mutated in gene tgl3 and it is a deletion mutation. The gene is expressed in lipid drops and it is responsible 
for breakdown of triacylglycerol.  
	
	
	
LIPID 
CLASS DME D0 D1 D2 D4 D6 D8 
PC 4.40E-02 1.96E-01 9.01E-02 1.57E-01 1.24E-01 3.39E-02 8.16E-03 
SO 6.84E+00 7.96E+00 9.50E+00 6.66E+00 6.34E+00 8.48E+00 7.41E+00 
TG 1.40E+00 1.57E+00 1.17E+00 1.31E+00 2.58E+00 5.86E-01 1.28E+00 
CER 3.32E-02 4.16E-01 1.91E-01 2.44E-01 2.85E-01 2.99E-01 2.69E-01 
CL 2.96E-02 8.77E-02 3.06E-02 9.92E-02 1.42E-01 8.06E-02 4.19E-02 
FA 1.65E+00 2.82E+00 8.34E-01 1.18E+00 1.11E+00 1.32E+00 7.94E-01 
PE 1.24E-01 1.91E-01 9.43E-02 1.38E-01 1.87E-01 1.07E-01 6.65E-02 
PG 7.31E-04 2.57E-03 6.69E-04 2.35E-03 2.50E-03 1.28E-03 0.00E+00 
PI 1.88E-01 2.60E-01 1.44E-01 8.31E-02 1.57E-01 6.33E-02 3.13E-02 
PS 1.53E-01 2.35E-01 4.52E-01 5.37E-01 5.88E-01 2.94E-01 6.22E-01 
Table 163.	Standard deviation values for mutant strain 8 lipid classes identified by the developed 
LC-MS/MS method in cells grown without PE21. The values are calculated as the sample standard 
deviation (±%) of two experiments for the wild type strain taken at 7 time points (DME, D0, D1, D2, D4, D6, 
D8). Sample standard deviation was used because the sample is biological. Legend: DME stands for day 
mid-exponential. D stands for day and numeric values represent days of growth. Lipid class: 
Phosphatidylcholine, Sphingosine, Triacylglycerol, Ceramide, Cardiolipin, Free Fatty Acid, 
Phosphatidylethanolamine, Phosphatidylglycerol, Phosphatidylinositol, Phosphatidylserine. Mutant strain 8 
is mutated in gene tgl3 and it is a deletion mutation. The gene is expressed in lipid drops and it is responsible 
for breakdown of triacylglycerol. 
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LIPID 
CLASS DME D0 D1 D2 D4 D6 D8 
PC 1.27E+00 2.94E+00 5.06E+00 1.88E+00 1.13E+00 1.47E+00 2.63E-01 
SO 5.13E+01 2.96E+01 3.38E+01 4.01E+01 2.17E+01 5.93E+01 5.95E+01 
TG 2.07E+01 3.58E+01 1.89E+01 1.53E+01 2.16E+01 2.64E+01 1.85E+01 
CER 3.61E+00 3.60E+00 5.66E+00 2.70E+00 3.57E+00 4.31E+00 3.63E+00 
CL 2.10E-01 2.52E-01 1.32E+00 5.30E-01 8.47E-01 9.99E-01 1.54E+00 
FA 4.04E+00 9.64E+00 1.02E+01 5.53E-01 6.55E+00 8.41E+00 6.02E+00 
PE 4.64E+00 3.03E+00 7.44E+00 3.03E+00 3.17E+00 2.16E+00 8.93E-01 
PG 3.77E-02 6.41E-02 1.38E-01 3.11E-02 3.82E-02 4.71E-02 1.56E-02 
PI 2.74E+00 3.57E+00 5.02E+00 2.39E+00 1.94E+00 1.38E+00 6.48E-01 
PS 2.47E+00 3.33E+00 5.25E+00 1.66E+01 3.17E+01 3.31E+00 1.53E+00 
Table 174.	Mean percentage values for mutant strain 9 lipid classes identified by the developed LC-
MS/MS method in cells grown without PE21. The values are the mean (% of whole lipidome) of two 
experiments for the wild type strain taken at 7 time points (DME, D0, D1, D2, D4, D6, D8). Legend: DME 
stands for day mid-exponential. D stands for day and numeric values represent days of growth. Lipid class: 
Phosphatidylcholine, sphingosine, Triacylglycerol, Ceramide, Cardiolipin, Free Fatty Acid, 
Phosphatidylethanolamine, Phosphatidylglycerol, Phosphatidylinositol, Phosphatidylserine. Mutant strain 9 
is mutated in gene tgl1 and it is a deletion mutation. The gene is expressed in lipid drops and it is responsible 
for breakdown of triacylglycerol.	
	
	
LIPID 
CLASS DME D0 D1 D2 D4 D6 D8 
PC 1.46E-01 3.37E-01 7.07E-01 2.47E-01 1.39E-01 1.45E-01 3.46E-02 
SO 4.22E+00 4.91E+00 3.88E+00 5.95E+00 3.79E+00 6.80E+00 7.81E+00 
TG 3.43E+00 5.00E+00 1.54E+00 2.67E+00 3.58E+00 1.41E+00 1.97E+00 
CER 4.00E-01 3.77E-01 5.93E-01 3.16E-01 3.52E-01 4.77E-01 3.81E-01 
CL 2.06E-02 2.68E-02 1.74E-01 6.08E-02 8.33E-02 1.75E-01 2.15E-01 
FA 8.44E-01 1.51E+00 3.25E+00 1.47E+00 1.48E+00 1.80E+00 9.99E-01 
PE 6.10E-01 4.24E-01 1.23E+00 4.23E-01 4.70E-01 3.40E-01 1.48E-01 
PG 4.17E-03 4.73E-03 1.19E-02 2.10E-03 4.00E-03 5.50E-03 1.63E-03 
PI 3.38E-01 4.10E-01 6.17E-01 3.14E-01 2.07E-01 2.41E-01 1.02E-01 
PS 2.54E-01 3.25E-01 5.15E-01 1.43E+00 2.41E+00 1.99E-01 1.19E-01 
Table 185.	Standard deviation values for mutant strain 9 lipid classes identified by the developed 
LC-MS/MS method in cells grown without PE21. The values are calculated as the sample standard 
deviation (±%) of two experiments for the wild type strain taken at 7 time points (DME, D0, D1, D2, D4, D6, 
D8). Sample standard deviation was used because the sample is biological. Legend: DME stands for day 
mid-exponential. D stands for day and numeric values represent days of growth. Lipid class: 
Phosphatidylcholine, Sphingosine, Triacylglycerol, Ceramide, Cardiolipin, Free Fatty Acid, 
Phosphatidylethanolamine, Phosphatidylglycerol, Phosphatidylinositol, Phosphatidylserine. Mutant strain 9 
is mutated in gene tgl1 and it is a deletion mutation. The gene is expressed in lipid drops and it is responsible 
for breakdown of triacylglycerol.	
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LIPID 
CLASS DME D0 D1 D2 D4 D6 D8 
PC 1.17E+00 1.61E+00 1.33E+00 1.29E+00 1.48E-01 1.45E-01 1.45E-01 
SO 2.92E+01 6.63E+00 7.57E+00 1.50E+01 2.51E+01 2.59E+01 2.02E+01 
TG 7.08E+00 1.01E+01 1.89E+01 4.65E-01 2.16E+01 2.64E+01 3.89E+01 
CER 4.72E+00 2.38E+00 1.98E+00 1.76E+00 4.89E+00 4.89E+00 5.18E+00 
CL 1.01E+00 8.91E-01 1.19E+00 1.04E+00 1.83E+00 1.79E+00 7.88E+00 
FA 4.04E+00 9.63E+00 8.22E+00 5.53E-01 6.55E+00 8.41E+00 6.46E+00 
PE 3.47E+00 2.85E+00 2.53E+00 2.06E+00 9.48E-01 9.69E-01 5.63E-01 
PG 1.11E-02 4.18E-02 4.45E-02 5.50E-02 1.13E-02 1.12E-02 0.00E+00 
PI 1.22E+00 7.44E-01 6.02E-01 4.27E-01 2.43E-01 2.47E-01 1.74E-01 
PS 3.49E+01 6.49E+01 7.29E+01 6.72E+01 3.49E+01 3.49E+01 8.33E+00 
Table 196.	Mean percentage values for mutant strain 87 lipid classes identified by the developed 
LC-MS/MS method in cells grown without PE21. The values are the mean (% of whole lipidome) of two 
experiments for the wild type strain taken at 7 time points (DME, D0, D1, D2, D4, D6, D8). Legend: DME 
stands for day mid-exponential. D stands for day and numeric values represent days of growth. Lipid class: 
Phosphatidylcholine, sphingosine, Triacylglycerol, Ceramide, Cardiolipin, Free Fatty Acid, 
Phosphatidylethanolamine, Phosphatidylglycerol, Phosphatidylinositol, Phosphatidylserine. Mutant strain 
87 is mutated in gene tgl4 and it is a deletion mutation. The gene is expressed in lipid drops and it is 
responsible for breakdown of triacylglycerol. 
	
	
	
	
	
	
LIPID 
CLASS DME D0 D1 D2 D4 D6 D8 
PC 1.15E-01 2.54E-01 1.98E-01 1.91E-01 1.45E-02 1.79E-02 2.15E-02 
SO 3.84E+00 9.84E-01 1.06E+00 1.48E+00 3.73E+00 2.55E+00 3.35E+00 
TG 7.53E-01 1.11E+00 3.55E-01 1.64E-01 2.36E+00 2.76E+00 5.11E+00 
CER 4.07E-01 2.35E-01 2.20E-01 2.06E-01 5.99E-01 5.99E-01 5.11E-01 
CL 1.41E-01 1.25E-01 1.17E-01 1.46E-01 2.40E-01 2.97E-01 1.31E+00 
FA 2.28E+00 1.68E+00 1.36E+00 9.07E-01 1.89E+00 1.35E+00 1.16E+00 
PE 5.15E-01 3.74E-01 3.32E-01 2.36E-01 1.49E-01 1.19E-01 9.85E-02 
PG 1.17E-03 4.89E-03 5.47E-03 5.43E-03 1.38E-03 1.31E-03 0.00E+00 
PI 1.20E-01 9.77E-02 6.91E-02 7.47E-02 3.40E-02 2.84E-02 3.04E-02 
PS 3.29E+00 5.80E+00 1.01E+01 5.09E+00 3.50E+00 3.27E+00 8.17E-01 
Table 207.	Standard deviation values for mutant strain 87 lipid classes identified by the developed 
LC-MS/MS method in cells grown without PE21. The values are calculated as the sample standard 
deviation (±%) of two experiments for the wild type strain taken at 7 time points (DME, D0, D1, D2, D4, D6, 
D8). Sample standard deviation was used because the sample is biological. Legend: DME stands for day 
mid-exponential. D stands for day and numeric values represent days of growth. Lipid class: 
Phosphatidylcholine, Sphingosine, Triacylglycerol, Ceramide, Cardiolipin, Free Fatty Acid, 
Phosphatidylethanolamine, Phosphatidylglycerol, Phosphatidylinositol, Phosphatidylserine. Mutant strain 
87 is mutated in gene tgl4 and it is a deletion mutation. The gene is expressed in lipid drops and it is 
responsible for breakdown of triacylglycerol. 
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LIPID 
CLASS DME D0 D1 D2 D4 D6 D8 
PC 6.57E-01 1.79E+00 2.38E+00 3.11E+00 6.70E-01 5.65E-01 8.11E-01 
SO 4.46E+01 2.69E+01 7.59E+00 1.98E+01 3.94E+01 3.75E+01 4.27E+01 
TG 2.27E+01 1.01E+01 1.89E+01 4.65E-01 2.16E+01 2.64E+01 1.47E+01 
CER 8.00E-01 1.48E+00 1.65E+00 2.90E+00 4.12E+00 6.34E+00 6.18E+00 
CL 2.58E+00 3.21E+01 1.98E+01 9.42E+00 1.96E+00 3.93E+00 9.40E+00 
FA 4.04E+00 4.07E+00 5.98E+00 5.53E-01 6.55E+00 8.41E+00 6.46E+00 
PE 2.22E+00 1.93E+00 3.69E+00 3.51E+00 1.69E+00 1.57E+00 2.27E+00 
PG 0.00E+00 2.90E-02 5.64E-02 3.97E-02 1.59E-02 1.33E-02 2.61E-02 
PI 2.21E+00 1.70E+00 1.97E+00 2.91E+00 1.67E+00 1.17E+00 1.43E+00 
PS 1.38E+01 1.39E+01 4.53E+01 3.69E+01 2.77E+01 2.46E+01 2.02E+01 
Table 218.	Mean percentage value of mutant strain 88 lipid classes identified by developed LC-
MS/MS method when grown without PE21. The values are the mean (% of whole lipidome) of two 
experiments for the wild type strain taken at 7 time points (DME, D0, D1, D2, D4, D6, D8). Legend: DME 
stands for day mid-exponential. D stands for day and numeric values represent days of growth. Lipid class: 
Phosphatidylcholine, sphingosine, Triacylglycerol, Ceramide, Cardiolipin, Free Fatty Acid, 
Phosphatidylethanolamine, Phosphatidylglycerol, Phosphatidylinositol, Phosphatidylserine. Mutant strain 
88 is mutated in gene tgl5 and it is a deletion mutation. The gene is expressed in lipid drops and it is 
responsible for breakdown of triacylglycerol. 
	
	
	
	
LIPID 
CLASS DME D0 D1 D2 D4 D6 D8 
PC 1.09E-01 2.20E-01 3.53E-01 5.16E-01 6.59E-02 6.01E-02 1.20E-01 
SO 6.63E+00 3.09E+00 7.46E-01 2.60E+00 6.20E+00 4.30E+00 5.61E+00 
TG 2.05E+00 9.60E-01 9.70E-01 1.11E+00 2.02E-01 1.06E+00 2.51E-01 
CER 5.90E-02 1.82E-01 1.73E-01 2.68E-01 5.29E-01 5.47E-01 5.72E-01 
CL 2.13E-01 5.60E+00 2.93E+00 1.40E+00 2.58E-01 4.84E-01 1.08E+00 
FA 5.01E-01 4.66E-01 1.05E+00 1.16E+00 2.39E+00 2.43E+00 1.20E+00 
PE 2.91E-01 2.70E-01 5.17E-01 5.51E-01 1.94E-01 2.20E-01 2.41E-01 
PG 0.00E+00 2.14E-03 6.59E-03 3.43E-03 2.04E-03 1.48E-03 2.09E-03 
PI 2.35E-01 2.24E-01 2.75E-01 4.06E-01 1.64E-01 1.25E-01 2.49E-01 
PS 1.45E+00 1.71E+00 3.05E+00 3.65E+00 2.90E+00 1.97E+00 1.87E+00 
Table 3922.	Standard deviation of mutant strain 88 lipid classes identified by developed LC-MS/MS 
method when grown without PE21. The values are calculated as the sample standard deviation (±%) of 
two experiments for the wild type strain taken at 7 time points (DME, D0, D1, D2, D4, D6, D8). Sample 
standard deviation was used because the sample is biological. Legend: DME stands for day mid-
exponential. D stands for day and numeric values represent days of growth. Lipid class: 
Phosphatidylcholine, Sphingosine, Triacylglycerol, Ceramide, Cardiolipin, Free Fatty Acid, 
Phosphatidylethanolamine, Phosphatidylglycerol, Phosphatidylinositol, Phosphatidylserine. Mutant strain 
88 is mutated in gene tgl5 and it is a deletion mutation. The gene is expressed in lipid drops and it is 
responsible for breakdown of triacylglycerol. 
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Figure 14.  The mean mole % values of Triacylglycerol (TG) relative to the whole lipidome for wild-
type strain compared to mutant strain 8 in cells grown without PE21. TG species were measured by 
the developed LC-MS/MS method at 7 time points. Error bars presented are from table 33 and mole % 
values are from table 32 for the mutant and tables 30 and 31 for wild type. For growth conditions of control 
and treated with 21 refer to Materials and Methods in chapter 3. Legend:DME stands for day mid-
exponential. D stands for day and numeric values represent days of growth. PE21 stands for plant extract 
21. Mutant strain 8 is mutated in gene tgl3 and it is a deletion mutation. The gene is expressed in lipid drops 
and it is responsible for breakdown of triacylglycerol. Control stands for wild type Saccharomyces 
cerevisiae. The mean and n value of standard deviation is from 2 experiments.  
	
	
	
Figure 15.	The mean mole % values of Free fatty acid (FFA) relative to the whole lipidome for wild-
type strain compared to mutant strain 8 in cells grown without PE21. FFA species were measured 
by the developed LC-MS/MS method at 7 time points. Error bars presented are from table 33 and mole 
% values are from table 32 for the mutant and tables 30 and 31 for wild type. For growth conditions of 
control and treated with 21 refer to Materials and Methods in chapter 3. Legend:DME stands for day mid-
exponential. D stands for day and numeric values represent days of growth. PE21 stands for plant extract 
21. Mutant strain 8 is mutated in gene tgl3 and it is a deletion mutation. The gene is expressed in lipid drops 
and it is responsible for breakdown of triacylglycerol. Control stands for wild type Saccharomyces 
cerevisiae. The mean and n value of standard deviation is from 2 experiments. 
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Figure 16.	The mean mole % values of Triacylglycerol (TG) relative to the whole lipidome for wild-
type strain compared to mutant strain 9 when in cells grown without PE21. TG species were 
measured by the developed LC-MS/MS method at 7 time points. Error bars presented are from table 
35 and mole % values are from table 34 for the mutant and tables 30 and 31 for wild type. For growth 
conditions of control and treated with 21 refer to Materials and Methods in chapter 3. Legend: DME stands 
for day mid-exponential. D stands for day and numeric values represent days of growth. PE21 stands for 
plant extract 21. Mutant strain 9 is mutated in gene tgl1 and it is a deletion mutation. The gene is expressed 
in lipid drops and it is responsible for breakdown of triacylglycerol. Control stands for wild type 
Saccharomyces cerevisiae. The mean and n value of standard deviation is from 2 experiments. 
	
	
Figure 17. The mean mole % values of Free fatty acids (FFA) relative to the whole lipidome for wild-
type strain compared to mutant strain 9 in cells grown without PE21. FFA species were measured 
by the developed LC-MS/MS method at 7 time points. Error bars presented are from table 35 and mole 
% values are from table 34 for the mutant and tables 30 and 31 for wild type. For growth conditions of 
control and treated with 21 refer to Materials and Methods in chapter 3. Legend:DME stands for day mid-
exponential. D stands for day and numeric values represent days of growth. PE21 stands for plant extract 
21. Mutant strain 9 is mutated in gene tgl1 and it is a deletion mutation. The gene is expressed in lipid drops 
and it is responsible for breakdown of triacylglycerol. Control stands for wild type Saccharomyces 
cerevisiae. The mean and n value of standard deviation is from 2 experiments. 
0.00E+00 
1.00E-01 
2.00E-01 
3.00E-01 
4.00E-01 
5.00E-01 
DME D0	 D1 D2 D4 D6 D8
M
OL
E	
%
HU
ND
RE
DS
TIME	POINTS	(DAYS)
Triacylglycerol
MUTANT CONTROL
-5.00E-02 
0.00E+00 
5.00E-02 
1.00E-01 
1.50E-01 
2.00E-01 
2.50E-01 
DME D0	 D1 D2 D4 D6 D8
M
OL
E	
% HU
ND
RE
DS
TIME	POINTS	(DAYS)
Free	Fatty	Acids
CONTROL MUTANT
	 76	
	
Figure 18. The mean mole % values of Triacylglycerol (TG) relative to the whole lipidome for wild-
type strain compared to mutant strain 87 in cells grown without PE21. TG species were measured 
by the developed LC-MS/MS method at 7 time points. Error bars presented are from table 37 and mole 
% values are from table 36 for the mutant and tables 30 and 31 for wild type. For growth conditions of 
control and treated with 21 refer to Materials and Methods in chapter 3. Legend:DME stands for day mid-
exponential. D stands for day and numeric values represent days of growth. PE21 stands for plant extract 
21. Mutant strain 87 is mutated in gene tgl4 and it is a deletion mutation. The gene is expressed in lipid 
drops and it is responsible for breakdown of triacylglycerol. Control stands for wild type Saccharomyces 
cerevisiae. The mean and n value of standard deviation is from 2 experiments. 
	
Figure 19. The mean mole % values of Free Fatty Acids (FFA) relative to the whole lipidome for wild-
type strain compared to mutant strain 87 when in cells grown without PE21. FFA species were 
measured by the developed LC-MS/MS method at 7 time points. Error bars presented are from table 
37 and mole % values are from table 36 for the mutant and tables 30 and 31 for wild type. For growth 
conditions of control and treated with 21 refer to Materials and Methods in chapter 3. Legend:DME stands 
for day mid-exponential. D stands for day and numeric values represent days of growth. PE21 stands for 
plant extract 21. Mutant strain 87 is mutated in gene tgl4 and it is a deletion mutation. The gene is expressed 
in lipid drops and it is responsible for breakdown of triacylglycerol. Control stands for wild type 
Saccharomyces cerevisiae. The mean and n value of standard deviation is from 2 experiments. 
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Figure 20. The mean mole % values of Triacylglycerol (TG) relative to the whole lipidome for wild-
type strain compared to mutant strain 88 in cells were grown without PE21. TG species were 
measured by the developed LC-MS/MS method at 7 time points. Error bars presented are from table 
39 and mole % values are from table 38 for the mutant and tables 30 and 31 for wild type. For growth 
conditions of control and treated with 21 refer to Materials and Methods in chapter 3. Legend:DME stands 
for day mid-exponential. D stands for day and numeric values represent days of growth. PE21 stands for 
plant extract 21. Mutant strain 88 is mutated in gene tgl5 and it is a deletion mutation. The gene is expressed 
in lipid drops and it is responsible for breakdown of triacylglycerol. Control stands for wild type 
Saccharomyces cerevisiae. The mean and n value of standard deviation is from 2 experiments. 
	
Figure 21. The mean mole % values of Free Fatty Acids (FFA) relative to the whole lipidome for wild-
type strain compared to mutant strain 88 in cells e grown without PE21. FFA species were measured 
by the developed LC-MS/MS method at 7 time points. Error bars presented are from table 39 and mole 
% values are from table 38 for the mutant and tables 30 and 31 for wild type. For growth conditions of 
control and treated with 21 refer to Materials and Methods in chapter 3. Legend:DME stands for day mid-
exponential. D stands for day and numeric values represent days of growth. PE21 stands for plant extract 
21. Mutant strain 88 is mutated in gene tgl5 and it is a deletion mutation. The gene is expressed in lipid 
drops and it is responsible for breakdown of triacylglycerol. Control stands for wild type Saccharomyces 
cerevisiae. The mean and n value of standard deviation is from 2 experiments. 
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3.5	 Tables and figures of various lipid classes for wild-type and 4 mutant strains 
impaired in lipid metabolism when the cells were cultured with PE21 
 
LIPID 
CLASS DME D0 D1 D2 D4 D6 D8 
PC 1.81E+00 3.90E+00 3.26E+00 3.43E+00 1.87E+00 1.02E+00 7.85E-01 
SO 6.71E+01 5.36E+01 3.21E+01 3.43E+01 3.33E+01 3.83E+01 5.58E+01 
TG 2.03E+01 1.98E+01 2.67E+01 2.51E+01 7.80E+00 1.78E+01 1.25E+01 
CER 2.94E+00 4.05E+00 4.36E+00 3.73E+00 2.09E+00 2.79E+00 3.11E+00 
CL 1.93E-01 5.38E-01 5.41E-01 5.05E-01 5.53E-01 7.06E-01 6.11E-01 
FA 1.32E+00 1.07E+00 1.46E+00 1.60E+00 6.40E-01 5.46E-01 9.93E-01 
PE 5.49E+00 6.57E+00 1.07E+01 8.04E+00 6.70E+00 5.66E+00 3.96E+00 
PG 1.10E-02 6.37E-02 2.03E-01 8.44E-02 6.23E-02 3.10E-02 0.00E+00 
PI 2.38E+00 2.20E+00 3.57E+00 2.26E+00 1.34E+00 8.99E-01 7.90E-01 
PS 1.37E+00 4.24E-01 9.75E+00 1.46E+01 4.20E+01 2.81E+01 1.50E+01 
Table 40. Mean percentage value of wild type lipid classes identified by developed LC-MS/MS 
method when grown with PE21. The values are the mean (% of whole lipidome) of two experiments for 
the wild type strain taken at 7 time points (DME, D0, D1, D2, D4, D6, D8). Legend: DME stands for day 
mid-exponential. D stands for day and numeric values represent days of growth. Lipid class: 
Phosphatidylcholine, sphingosine, Triacylglycerol, Ceramide, Cardiolipin, Free Fatty Acid, 
Phosphatidylethanolamine, Phosphatidylglycerol, Phosphatidylinositol, Phosphatidylserine. 
	
	
	
LIPID 
CLASS DME D0 D1 D2 D4 D6 D8 
PC 1.81E+00 3.90E+00 3.26E+00 3.43E+00 1.87E+00 1.02E+00 7.85E-01 
SO 6.71E+01 5.36E+01 3.21E+01 3.43E+01 3.33E+01 3.83E+01 5.58E+01 
TG 2.03E+01 1.98E+01 2.67E+01 2.51E+01 7.80E+00 1.78E+01 1.25E+01 
CER 2.94E+00 4.05E+00 4.36E+00 3.73E+00 2.09E+00 2.79E+00 3.11E+00 
CL 1.93E-01 5.38E-01 5.41E-01 5.05E-01 5.53E-01 7.06E-01 6.11E-01 
FA 1.32E+00 1.07E+00 1.46E+00 1.60E+00 6.40E-01 5.46E-01 9.93E-01 
PE 5.49E+00 6.57E+00 1.07E+01 8.04E+00 6.70E+00 5.66E+00 3.96E+00 
PG 1.10E-02 6.37E-02 2.03E-01 8.44E-02 6.23E-02 3.10E-02 0.00E+00 
PI 2.38E+00 2.20E+00 3.57E+00 2.26E+00 1.34E+00 8.99E-01 7.90E-01 
PS 1.37E+00 4.24E-01 9.75E+00 1.46E+01 4.20E+01 2.81E+01 1.50E+01 
Table 41. Standard deviation of wild type lipid classes identified by developed LC-MS/MS method 
when grown with PE21. The values are calculated as the sample standard deviation (±%) of two 
experiments for the wild type strain taken at 7 time points (DME, D0, D1, D2, D4, D6, D8). Sample standard 
deviation was used because the sample is biological. Legend: DME stands for day mid-exponential. D 
stands for day and numeric values represent days of growth. Lipid class: Phosphatidylcholine, Sphingosine, 
Triacylglycerol, Ceramide, Cardiolipin, Free Fatty Acid, Phosphatidylethanolamine, Phosphatidylglycerol, 
Phosphatidylinositol, Phosphatidylserine. 
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LIPID 
CLASS DME D0 D1 D2 D4 D6 D8 
PC 8.29E-01 1.26E+00 5.93E-01 2.09E+00 1.87E+00 3.02E+00 1.04E+00 
SO 7.90E+01 6.73E+01 7.43E+01 4.28E+01 4.33E+01 3.79E+01 2.14E+01 
TG 2.03E+01 1.98E+01 2.67E+01 2.51E+01 7.80E+00 1.78E+01 1.25E+01 
CER 2.13E+00 3.29E+00 1.50E+00 3.19E+00 2.57E+00 2.18E+00 0.00E+00 
CL 1.08E-01 3.69E-01 3.67E-01 1.56E+00 2.24E+00 4.29E+00 0.00E+00 
FA 1.20E+00 1.07E+00 1.06E+00 1.60E+00 6.40E-01 5.46E-01 0.00E+00 
PE 1.13E+00 2.28E+00 1.24E+00 2.98E+00 3.38E+00 4.34E+00 0.00E+00 
PG 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 3.64E-02 0.00E+00 
PI 3.81E+00 4.74E+00 2.04E+00 4.69E+00 5.15E+00 3.20E+00 0.00E+00 
PS 2.20E+00 6.56E+00 2.97E+00 1.01E+01 2.71E+01 2.22E+01 0.00E+00 
Table 42. Mean percentage values for mutant strain 8 lipid classes identified by the developed LC-
MS/MS method in cells grown with PE21. The values are the mean (% of whole lipidome) of two 
experiments for the wild type strain taken at 7 time points (DME, D0, D1, D2, D4, D6, D8). Legend: DME 
stands for day mid-exponential. D stands for day and numeric values represent days of growth. Lipid class: 
Phosphatidylcholine, sphingosine, Triacylglycerol, Ceramide, Cardiolipin, Free Fatty Acid, 
Phosphatidylethanolamine, Phosphatidylglycerol, Phosphatidylinositol, Phosphatidylserine. Mutant strain 8 
has the entire gene Tgl3 deleted. The protein product of this gene resides in lipid droplets and is responsible 
for breakdown of triacylglycerol.  
	
	
	
	
	
	
LIPID 
CLASS DME D0 D1 D2 D4 D6 D8 
PC 7.67E-02 1.87E-01 1.04E-01 2.40E-01 2.15E-01 4.74E-01 1.28E-01 
SO 8.75E+00 7.72E+00 1.17E+01 5.26E+00 5.68E+00 4.35E+00 2.81E+00 
TG 1.27E+00 6.14E-01 9.42E-01 4.15E+00 1.04E+00 2.29E+00  
CER 2.62E-01 2.43E-01 1.75E-01 2.35E-01 2.54E-01 2.41E-01  
CL 1.60E-02 4.85E-02 4.51E-02 2.58E-01 2.20E-01 6.00E-01  
FA 8.07E-02 2.43E-01 1.40E-01 2.89E-01 2.09E-01 1.16E-01  
PE 1.38E-01 2.99E-01 1.73E-01 4.17E-01 3.87E-01 6.07E-01  
PG 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 4.68E-03  
PI 3.99E-01 7.86E-01 3.02E-01 7.78E-01 5.90E-01 3.67E-01  
PS 2.57E-01 4.42E-01 2.19E-01 9.99E-01 2.50E+00 2.05E+00  
Table 233. Standard deviation values for mutant strain 8 lipid classes identified by the developed 
LC-MS/MS method in cells grown with PE21. The values are calculated as the sample standard deviation 
(±%) of two experiments for the wild type strain taken at 7 time points (DME, D0, D1, D2, D4, D6, D8). 
Sample standard deviation was used because the sample is biological. Legend: DME stands for day mid-
exponential. D stands for day and numeric values represent days of growth. Lipid class: 
Phosphatidylcholine, Sphingosine, Triacylglycerol, Ceramide, Cardiolipin, Free Fatty Acid, 
Phosphatidylethanolamine, Phosphatidylglycerol, Phosphatidylinositol, Phosphatidylserine. Mutant strain 8 
has the entire gene Tgl3 deleted. The protein product of this gene resides in lipid droplets and is responsible 
for breakdown of triacylglycerol. 
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LIPID 
CLASS DME D0 D1 D2 D4 D6 D8 
PC 3.49E+00 2.05E+00 4.08E+00 3.38E+00 4.65E+00 3.94E+00 4.20E+00 
SO 6.41E+01 3.92E+01 2.64E+01 5.31E+01 2.06E+01 4.26E+01 2.99E+01 
TG 2.03E+01 3.38E+01 3.27E+01 2.51E+01 1.88E+01 1.78E+01 2.43E+01 
CER 9.89E-01 2.24E+00 2.81E+00 8.62E-01 3.55E+00 2.60E+00 2.83E+00 
CL 5.05E-01 3.80E-01 7.15E-01 9.08E-01 3.34E+00 1.71E+00 1.78E+00 
FA 1.32E+00 8.14E-01 1.46E+00 9.54E-01 6.40E-01 5.46E-01 9.97E-01 
PE 7.40E+00 2.84E+00 5.25E+00 4.17E+00 7.69E+00 5.06E+00 3.97E+00 
PG 0.00E+00 0.00E+00 1.32E-02 2.67E-02 7.76E-02 4.54E-02 4.90E-02 
PI 7.40E+00 4.42E+00 4.19E+00 4.18E+00 4.59E+00 3.75E+00 4.68E+00 
PS 7.81E+00 7.14E+00 1.80E+01 1.33E+01 3.35E+01 2.65E+01 2.23E+01 
Table 244. Mean percentage values for mutant strain 9 lipid classes identified by the developed LC-
MS/MS method in cells grown with PE21. The values are the mean (% of whole lipidome) of two 
experiments for the wild type strain taken at 7 time points (DME, D0, D1, D2, D4, D6, D8). Legend: DME 
stands for day mid-exponential. D stands for day and numeric values represent days of growth. Lipid class: 
Phosphatidylcholine, sphingosine, Triacylglycerol, Ceramide, Cardiolipin, Free Fatty Acid, 
Phosphatidylethanolamine, Phosphatidylglycerol, Phosphatidylinositol, Phosphatidylserine. Mutant strain 9 
has the entire gene Tgl1 deleted. The protein product of this gene resides in lipid droplets and is responsible 
for breakdown of triacylglycerol.	
	
	
	
	
LIPID 
CLASS DME D0 D1 D2 D4 D6 D8 
PC 3.65E-01 3.58E-01 4.68E-01 5.60E-01 4.95E-01 6.89E-01 6.24E-01 
SO 6.72E+00 4.82E+00 3.03E+00 5.66E+00 2.02E+00 6.33E+00 3.93E+00 
TG 1.74E+00 4.45E+00 3.21E+00 1.59E+00 1.85E+00 9.61E-01 3.82E+00 
CER 1.05E-01 2.35E-01 2.60E-01 1.11E-01 2.62E-01 2.25E-01 2.79E-01 
CL 6.64E-02 3.73E-02 8.79E-02 1.43E-01 3.83E-01 2.39E-01 2.96E-01 
FA 1.97E-01 1.07E-01 2.34E-01 1.09E-01 1.19E-01 7.44E-02 1.14E-01 
PE 6.85E-01 4.47E-01 6.02E-01 6.56E-01 1.08E+00 7.51E-01 6.94E-01 
PG 0.00E+00 0.00E+00 8.88E-04 2.14E-03 9.06E-03 3.64E-03 3.61E-03 
PI 5.92E-01 7.33E-01 5.16E-01 4.11E-01 8.02E-01 6.55E-01 7.36E-01 
PS 7.23E-01 6.60E-01 1.66E+00 1.63E+00 3.51E+00 2.94E+00 2.86E+00 
Table 255.  Standard deviation values for mutant strain 9 lipid classes identified by the developed 
LC-MS/MS method when cells were grown with PE21. The values are calculated as the sample standard 
deviation (±%) of two experiments for the wild type strain taken at 7 time points (DME, D0, D1, D2, D4, D6, 
D8). Sample standard deviation was used because the sample is biological. Legend: DME stands for day 
mid-exponential. D stands for day and numeric values represent days of growth. Lipid class: 
Phosphatidylcholine, Sphingosine, Triacylglycerol, Ceramide, Cardiolipin, Free Fatty Acid, 
Phosphatidylethanolamine, Phosphatidylglycerol, Phosphatidylinositol, Phosphatidylserine. Mutant strain 9 
has the entire gene Tgl1 deleted. The protein product of this gene resides in lipid droplets and is responsible 
for breakdown of triacylglycerol.	
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LIPID 
CLASS DME D0 D1 D2 D4 D6 D8 
PC 1.30E+00 1.69E+00 1.17E+00 1.08E+00 1.04E+00 1.11E+00 7.63E-01 
SO 1.09E+01 1.56E+01 5.34E+00 2.57E+01 2.68E+01 9.46E+00 3.89E+00 
TG 2.03E+01 1.98E+01 2.67E+01 2.51E+01 7.80E+00 1.78E+01 1.25E+01 
CER 1.54E+00 2.22E+00 1.15E+00 1.35E+00 1.06E+00 9.02E-01 5.97E-01 
CL 1.63E+00 1.23E+00 1.83E+00 1.30E+00 4.37E+00 3.37E+00 5.39E+00 
FA 3.33E-01 3.18E-01 2.26E-01 2.89E-01 1.63E-01 1.32E-01 9.67E-02 
PE 3.53E+00 3.35E+00 2.95E+00 2.06E+00 1.56E+00 1.58E+00 1.39E+00 
PG 0.00E+00 0.00E+00 7.41E-03 7.26E-03 2.40E-02 3.12E-02 3.31E-02 
PI 5.43E+00 3.60E+00 2.65E+00 2.02E+00 1.75E+00 1.56E+00 1.06E+00 
PS 8.19E+01 6.55E+01 8.13E+01 5.84E+01 6.08E+01 8.36E+01 8.42E+01 
Table 266. Mean percentage values for mutant strain 87 lipid classes identified by the developed 
LC-MS/MS method in cells grown with PE21. The values are the mean (% of whole lipidome) of two 
experiments for the wild type strain taken at 7 time points (DME, D0, D1, D2, D4, D6, D8). Legend: DME 
stands for day mid-exponential. D stands for day and numeric values represent days of growth. Lipid class: 
Phosphatidylcholine, sphingosine, Triacylglycerol, Ceramide, Cardiolipin, Free Fatty Acid, 
Phosphatidylethanolamine, Phosphatidylglycerol, Phosphatidylinositol, Phosphatidylserine. Mutant strain 
87 has the entire gene Tgl4 deleted. The protein product of this gene resides in lipid droplets and is 
responsible for breakdown of triacylglycerol. 
	
	
	
	
	
LIPID 
CLASS DME D0 D1 D2 D4 D6 D8 
PC 1.12E-01 2.50E-01 1.84E-01 1.06E-01 1.63E-01 1.55E-01 8.12E-02 
SO 1.27E+00 2.18E+00 5.25E-01 3.59E+00 3.98E+00 1.49E+00 3.83E-01 
TG 9.53E-02 9.21E-01 1.18E+00 8.29E-01 5.93E-01 2.61E-01 5.49E-01 
CER 1.39E-01 1.64E-01 8.50E-02 1.08E-01 1.11E-01 6.07E-02 6.26E-02 
CL 2.01E-01 1.72E-01 2.56E-01 1.71E-01 7.64E-01 4.14E-01 7.54E-01 
FA 3.49E-02 3.64E-02 3.76E-02 3.31E-02 2.85E-02 1.74E-02 1.35E-02 
PE 3.04E-01 3.84E-01 5.15E-01 2.36E-01 2.18E-01 2.35E-01 1.48E-01 
PG 0.00E+00 0.00E+00 7.76E-04 8.04E-04 1.61E-03 2.89E-03 2.65E-03 
PI 6.66E-01 5.97E-01 4.62E-01 2.83E-01 2.74E-01 2.32E-01 1.76E-01 
PS 8.08E+00 8.42E+00 9.01E+00 6.12E+00 7.82E+00 7.74E+00 5.67E+00 
Table 277. Standard deviation values for mutant strain 87 lipid classes identified by the developed 
LC-MS/MS method in cells grown with PE21. The values are calculated as the sample standard deviation 
(±%) of two experiments for the wild type strain taken at 7 time points (DME, D0, D1, D2, D4, D6, D8). 
Sample standard deviation was used because the sample is biological. Legend: DME stands for day mid-
exponential. D stands for day and numeric values represent days of growth. Lipid class: 
Phosphatidylcholine, Sphingosine, Triacylglycerol, Ceramide, Cardiolipin, Free Fatty Acid, 
Phosphatidylethanolamine, Phosphatidylglycerol, Phosphatidylinositol, Phosphatidylserine. Mutant strain 
87 has the entire gene Tgl4 deleted. The protein product of this gene resides in lipid droplets and is 
responsible for breakdown of triacylglycerol. 
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LIPID 
CLASS DME D0 D1 D2 D4 D6 D8 
PC 1.52E+00 4.66E+00 1.63E+00 2.57E+00 1.75E+00 1.41E+00 1.06E+00 
SO 1.73E+01 3.42E+01 1.49E+01 1.43E+01 5.52E+00 6.43E+00 9.57E+00 
TG 2.42E+01 1.98E+01 2.67E+01 2.51E+01 7.80E+00 1.78E+01 1.25E+01 
CER 2.60E+00 6.53E+00 2.39E+00 2.55E+00 1.07E+00 1.00E+00 5.15E-01 
CL 1.55E+00 8.33E+00 4.94E+00 3.05E+01 1.10E+01 1.72E+01 7.84E+00 
FA 6.54E-01 1.07E+00 7.95E-01 8.20E-01 2.72E-01 2.35E-01 1.27E-01 
PE 5.12E+00 1.25E+01 4.26E+00 4.64E+00 2.41E+00 2.43E+00 1.26E+00 
PG 0.00E+00 0.00E+00 5.09E-02 3.83E-02 6.08E-02 6.50E-02 6.49E-02 
PI 4.14E+00 8.31E+00 3.84E+00 3.23E+00 2.21E+00 1.62E+00 1.15E+00 
PS 4.59E+01 3.60E+00 4.09E+01 3.48E+01 6.98E+01 6.84E+01 7.69E+01 
Table 288.  Mean percentage value of mutant strain 88 lipid classes identified by developed LC-
MS/MS method when grown with PE21. The values are the mean (% of whole lipidome) of two 
experiments for the wild type strain taken at 7 time points (DME, D0, D1, D2, D4, D6, D8). Legend: DME 
stands for day mid-exponential. D stands for day and numeric values represent days of growth. Lipid class: 
Phosphatidylcholine, sphingosine, Triacylglycerol, Ceramide, Cardiolipin, Free Fatty Acid, 
Phosphatidylethanolamine, Phosphatidylglycerol, Phosphatidylinositol, Phosphatidylserine. Mutant strain 
88 has the entire gene Tgl5 deleted. The protein product of this gene resides in lipid droplets and is 
responsible for breakdown of triacylglycerol. 
	
	
	
	
	
	
LIPID 
CLASS DME D0 D1 D2 D4 D6 D8 
PC 1.22E-01 6.52E-01 2.28E-01 3.16E-01 2.75E-01 1.38E-01 1.86E-01 
SO 1.71E+00 4.49E+00 2.47E+00 1.76E+00 7.72E-01 1.07E+00 1.50E+00 
TG 2.78E+00 1.58E+00 2.80E+00 4.93E-01 1.25E+00 2.37E-01 4.02E-01 
CER 3.42E-01 6.05E-01 1.61E-01 1.72E-01 1.12E-01 6.75E-02 4.76E-02 
CL 2.71E-01 1.09E+00 4.85E-01 3.75E+00 1.93E+00 1.70E+00 1.37E+00 
FA 7.64E-02 2.26E-01 1.32E-01 8.06E-02 3.80E-02 3.91E-02 2.00E-02 
PE 6.59E-01 1.33E+00 6.69E-01 4.94E-01 2.76E-01 3.40E-01 2.08E-01 
PG 0.00E+00 0.00E+00 6.55E-03 4.01E-03 5.25E-03 4.79E-03 8.35E-03 
PI 3.57E-01 9.53E-01 6.04E-01 4.52E-01 2.35E-01 1.86E-01 1.41E-01 
PS 4.81E+00 3.33E-01 4.54E+00 3.65E+00 6.46E+00 4.61E+00 5.67E+00 
Table 4929. Standard deviation of mutant strain 88 lipid classes identified by developed LC-MS/MS 
method when grown with PE21. The values are calculated as the sample standard deviation (±%) of two 
experiments for the wild type strain taken at 7 time points (DME, D0, D1, D2, D4, D6, D8). Sample standard 
deviation was used because the sample is biological. Legend: DME stands for day mid-exponential. D 
stands for day and numeric values represent days of growth. Lipid class: Phosphatidylcholine, Sphingosine, 
Triacylglycerol, Ceramide, Cardiolipin, Free Fatty Acid, Phosphatidylethanolamine, Phosphatidylglycerol, 
Phosphatidylinositol, Phosphatidylserine. Mutant strain 88 has the entire gene Tgl5 deleted. The protein 
product of this gene resides in lipid droplets and is responsible for breakdown of triacylglycerol. 
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Figure 22.  The mean mole % values of Triacylglycerol (TG) relative to the whole lipidome for wild-
type strain compared to mutant strain 8 (tgl3D) when in cells grown with PE21. TG species were 
measured by the developed LC-MS/MS method at 7 time points. Error bars presented are from table 
43 and mole % values are from table 42. For growth conditions of control and treated with 21 refer to 
Materials and Methods in chapter 3. Legend: DME stands for day mid-exponential. D stands for day 
and numeric values represent days of growth. PE21 stands for plant extract 21. Mutant strain 8 is mutated 
in gene tgl3 and it is a deletion mutation. The gene is expressed in lipid drops and it is responsible for 
breakdown of triacylglycerol. Control stands for wild type Saccharomyces cerevisiae. The mean and n value 
of standard deviation are from 2 experiments.  
	
	
Figure 23.	The mean mole % values of Free fatty acid relative to the whole lipidome for wild-type 
strain compared to mutant strain 8 (tgl3D) in cells grown with PE21. FFA species were measured by 
the developed LC-MS/MS method at 7 time points. Error bars presented are from table 43 and mole % 
values are from table 42. For growth conditions of control and treated with 21 refer to Materials and Methods 
in chapter 3. Legend: DME stands for day mid-exponential. D stands for day and numeric values 
represent days of growth. PE21 stands for plant extract 21. Mutant strain 8 is mutated in gene tgl3 and it is 
a deletion mutation. The gene is expressed in lipid drops and it is responsible for breakdown of 
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triacylglycerol. Control stands for wild type Saccharomyces cerevisiae. The mean and n value of standard 
deviation are from 2 experiments. 
	
Figure 24.	The mean mole % values of Triacylglycerol (TG) relative to the whole lipidome for wild-
type strain compared to mutant strain 9 (tgl1D) in cells grown with PE21. TG species were measured 
by the developed LC-MS/MS method at 7 time points. Error bars presented are from table 45 and mole 
% values are from table 44. For growth conditions of control and treated with 21 refer to Materials and 
Methods in chapter 3. Legend: DME stands for day mid-exponential. D stands for day and numeric values 
represent days of growth. PE21 stands for plant extract 21. Mutant strain 9 is mutated in gene tgl1 and it is 
a deletion mutation. The gene is expressed in lipid drops and it is responsible for breakdown of 
triacylglycerol. Control stands for wild type Saccharomyces cerevisiae. The mean and n value of standard 
deviation are from 2 experiments. 
	
	
Figure 25. The mean mole % values of Free fatty acids (FFA) relative to the whole lipidome for wild-
type strain compared to mutant strain 9 (tgl1D) in cells grown with PE21. FFA species were 
measured by the developed LC-MS/MS method at 7 time points. Error bars presented are from table 
45 and mole % values are from table 44. For growth conditions of control and treated with 21 refer to 
Materials and Methods in chapter 3. Legend: DME stands for day mid-exponential. D stands for day 
and numeric values represent days of growth. PE21 stands for plant extract 21. Mutant strain 9 is mutated 
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in gene tgl1 and it is a deletion mutation. The gene is expressed in lipid drops and it is responsible for 
breakdown of triacylglycerol. Control stands for wild type Saccharomyces cerevisiae. The mean and n value 
of standard deviation are from 2 experiments. 
	
Figure 26. The mean mole % values of Triacylglycerol (TG) relative to the whole lipidome for wild-
type strain compared to mutant strain 87 (tgl4D) in cells grown with PE21. TG species were 
measured by the developed LC-MS/MS method at 7 time points. Error bars presented are from table 
47 and mole % values are from table 46. For growth conditions of control and treated with 21 refer to 
Materials and Methods in chapter 3. Legend: DME stands for day mid-exponential. D stands for day 
and numeric values represent days of growth. PE21 stands for plant extract 21. Mutant strain 87 is mutated 
in gene tgl4 and it is a deletion mutation. The gene is expressed in lipid drops and it is responsible for 
breakdown of triacylglycerol. Control stands for wild type Saccharomyces cerevisiae. The mean and n value 
of standard deviation are from 2 experiments. 
	
	
Figure 27. The mean mole % values of Free Fatty Acids (FFA) relative to the whole lipidome for wild-
type strain compared to mutant strain 87 (tgl4D) in cells grown with PE21. FFA species were 
measured by the developed LC-MS/MS method at 7 time points. Error bars presented are from table 
47 and mole % values are from table 46. For growth conditions of control and treated with 21 refer to 
Materials and Methods in chapter 3. Legend: DME stands for day mid-exponential. D stands for day 
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and numeric values represent days of growth. PE21 stands for plant extract 21. Mutant strain 87 is mutated 
in gene tgl4 and it is a deletion mutation. The gene is expressed in lipid drops and it is responsible for 
breakdown of triacylglycerol. Control stands for wild type Saccharomyces cerevisiae. The mean and n value 
of standard deviation are from 2 experiments. 
	
Figure 28. The mean mole % values of Triacylglycerol (TG) relative to the whole lipidome for wild-
type strain compared to mutant strain 88 (tgl5D) when in cells grown with PE21. TG species were 
measured by the developed LC-MS/MS method at 7 time points. Error bars presented are from table 
49 and mole % values are from table 48. For growth conditions of control and treated with 21 refer to 
Materials and Methods in chapter 3. Legend: DME stands for day mid-exponential. D stands for day 
and numeric values represent days of growth. PE21 stands for plant extract 21. Mutant strain 88 is mutated 
in gene tgl5 and it is a deletion mutation. The gene is expressed in lipid drops and it is responsible for 
breakdown of triacylglycerol. Control stands for wild type Saccharomyces cerevisiae. The mean and n value 
of standard deviation are from 2 experiments. 
	
	
Figure 29. The mean mole % values of Free Fatty Acids relative to the whole lipidome for wild-type 
strain compared to mutant strain 88 (tgl5D) in cells grown with PE21. FFA species were measured 
by the developed LC-MS/MS method at 7 time points. Error bars presented are from table 49 and mole 
% values are from table 48. For growth conditions of control and treated with 21 refer to Materials and 
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Methods in chapter 3. Legend: DME stands for day mid-exponential. D stands for day and numeric values 
represent days of growth. PE21 stands for plant extract 21. Mutant strain 88 is mutated in gene tgl5 and it 
is a deletion mutation. The gene is expressed in lipid drops and it is responsible for breakdown of 
triacylglycerol. Control stands for wild type Saccharomyces cerevisiae. The mean and n value of standard 
deviation are from 2 experiments. 
	
Figure 30. Viability curves of wild-type strain and the mutant strain 9 (tgl1D) cultured with and 
without PE21. Both mutant strain and wildtype cells were cultured initially in nutrient-rich YP medium 
containing 2% glucose, then the cells were transferred to a synthetic minimal YNB medium containing 2% 
glucose. The viability percentage values are relative to the number of viable cells at post-diauxic phase. 
The values reported are the mean of duplicate experiments. Mutant strain 9 is mutated in gene tgl1 and it 
is a deletion mutation. The gene is expressed in lipid drops and it is responsible for breakdown of 
triacylglycerol. Legends: YNB stands for yeast nitrogen base (without amino acids). YP stands for yeast 
extract and peptone.  
	
Figure 31.	 Viability curves of wild-type strain and the mutant strain 8 (tgl3D) cultured with and 
without PE21. Both mutant strain and wildtype cells were cultured initially in nutrient-rich YP medium 
containing 2% glucose, then the cells were transferred to a synthetic minimal YNB medium containing 2% 
glucose. The viability percentage values are relative to the number of viable cells at post-diauxic phase. 
The values reported are the mean of duplicate experiments. Mutant strain 8 is mutated I n gene tgl3 and it 
is a deletion mutation. The gene is expressed in lipid drops and it is responsible for breakdown of 
triacylglycerol. Legends: YNB stands for yeast nitrogen base (without amino acids). YP stands for yeast 
extract and peptone. 
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Figure 32. 	Viability curves of wild-type strain and the mutant strain 87 (tgl4D) cultured with and 
without PE21. Both mutant strain and wildtype cells were cultured initially in nutrient-rich YP medium 
containing 2% glucose, then the cells were transferred to a synthetic minimal YNB medium containing 2% 
glucose. The viability percentage values are relative to the number of viable cells at post-diauxic phase. 
The values reported are the mean of duplicate experiments. Mutant strain 87 is mutated in gene tgl4 and it 
is a deletion mutation. The gene is expressed in lipid drops and it is responsible for breakdown of 
triacylglycerol. Legends: YNB stands for yeast nitrogen base (without amino acids). YP stands for yeast 
extract and peptone. 
	
Figure 33.	Viability curves of wild-type strain and the mutant strain 88 (tgl5D) cultured with and 
without PE21. Both mutant strain and wildtype cells were cultured initially in nutrient-rich YP medium 
containing 2% glucose, then the cells were transferred to a synthetic minimal YNB medium containing 2% 
glucose. The viability percentage values are relative to the number of viable cells at post-diauxic phase. 
The values reported are the mean of duplicate experiments. Mutant strain 88 is mutated in gene tgl5 and it 
is a deletion mutation. The gene is expressed in lipid drops and it is responsible for breakdown of 
triacylglycerol. Legends: YNB stands for yeast nitrogen base (without amino acids). YP stands for yeast 
extract and peptone. 
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3.6 Results and discussion of sections 3.4 and 3.5 
 
Tables 30, 32, 34, 36 and 38 provide data on the mole percentages of 10 lipid 
classes of wild-type and 4 mutant strains that lack different isoforms of triacylglycerol 
lipases. The values reported in each table represent the mean of two experiments. The 
tables correspond to different strains as follows: 30 (wild-type strain), 32 (strain 8, tgl3Δ), 
34 (strain 9, tgl1Δ), 36 (strain 87, tgl4Δ) and 38 (strain 88, tgl5Δ). Tables 31, 33, 35, 37, 
and 39 show the standard deviation values of duplicate experiments for wild-type and 
these 4 mutant strains. The results shown in these tables indicate that standard deviations 
for different lipid classes vary between 5% to 20%. It is very unlikely that this variation is 
due to a detection or quantification error of the lipid analysis method developed by me; 
indeed, when the known concentrations of lipid standards were analyzed, there was less 
than 3% of variation between the 5 replicates as indicated in Section 2.0.  
Although the total cellular lipidomes of 11 mutants were defined and compared to 
the total cellular lipidome of wild-type strain, the study focus of my thesis was on 4 mutant 
strains. These total cellular lipidomes of 12 strains were analyzed when yeast cells were 
cultured with or without PE21. As mentioned earlier, the mutants were deficient in the acyl 
transferase enzymes involved in different pathways of lipid metabolism. The future study 
will focus on the effects of PE21 on specific pathways of lipid metabolism through which 
PE21 extends yeast CLS.  
Herein, the focus of the study is on 4 mutant strains. These mutant strains were 
impaired in 4 different enzymes, each of which catalyzes the breakdown of 
triacyclglycerols into free fatty acids. These enzymes reside in lipid droplets, which serve 
as a site for the storage of triacylglycerol molecules. In each of these 4 mutant strains, 
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the concentration of FFA is known to be lower than that in wild-type strain whereas the 
concentration of TAG is known to be higher than that in wild-type strain. The reason that 
these specific mutant strains were chosen for this study is that our finding presented in 
Section 3.3 (Figure 9) have revealed that PE21 considerably decreases the concentration 
of FFA. Unpublished data from the Titorenko suggest a hypothesis in which PE21 may 
increase yeast CLS because it decreases the rate of an age-related liponecrotic mode of 
programmed cell death (PCD).  
Liponecrosis is a newly discovered subroutine of PCD, which is triggered by an 
accumulation of palmitoleic acid (POA) and some other species of free fatty acids [125]. 
Excessive amounts of exogenous POA are either incorporated into 1) phospholipids (PL) 
found in intracellular membranes; or 2) neutral lipids (NL), such as triacylglycerols (TAG), 
found in lipid droplets (Figure 3). The buildup of POA-containing PLs in the plasma 
membrane (PM) disrupts the asymmetrical distribution of certain phospholipid species, 
thus leading to a decline in the concentration of phosphatidylethanolamine (PE) within the 
extracellular leaflet of the PM [125]. This triggers the Rim101 pathway, which is activated 
either in response to 1) alkalinizing of extracellular medium; or 2) changes in the 
asymmetry of the membrane leaflets [125]. Activated Rim101 stimulates transcription of 
the Rsp1 gene leading to an increase in the amounts of Rbs1p protein [125]. This 
stimulates shuttling of PE from the extracellular leaflet to the intracellular leaflet of the 
PM. This depletion of PE in the extracellular leaflet of the PM increases its permeability, 
thus allowing small molecules to diffuse into the cell and to induce liponecrosis [125]. 
POA-containing PLs can also be found in mitochondrial membranes. This disrupts 
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mitochondrial functionality and leads to the production of reactive oxygen species that 
damage macromolecules and organelles and commits the cell to liponecrosis [125]. 
Because POA and other unsaturated FFAs are prone to age-related oxidative 
damage, their incorporation into phospholipids is detrimental for the cells because it 
induces liponecrotic cell death [126]. Several cellular processes can protect yeast from 
these toxic FFAs and liponecrosis. These cellular processes include: 1) an incorporation 
of the toxic FFAs into triacylglycerols to alleviate oxidative damage to macromolecules in 
other cellular locations [126]; 2) an oxidation of these FFAs in peroxisomes to reduce their 
flow into phospholipids [125]; 3) a degradation of dysfunctional mitochondria through 
mitophagy; or 4) a degradation of damaged macromolecules to maintain cellular 
homeostasis [125]. Liponecrosis is a subroutine of PCD, which consists of a genetically 
programmed set of cellular processes that occur in a defined sequence of events. These 
processes can be modulated through mutations in genes encoding various proteins 
involved in lipid metabolism and maintenance of functional mitochondria [125]. 
 The results in Figures 30, 31, 32, and 33 of Section 3.5 support the above 
hypothesis. As we can see, all 4 mutant strains deficient in different triacylglycerol lipases 
live longer than wild-type strain cultured with without PE21. The difference between CLSs 
of wild-type and mutant strains is low in the absence of PE21; such difference is 
considerably enhanced in the presence of PE21. This finding suggests that the ability of 
PE21 to delay yeast chronological aging can be enhanced by decreasing the 
concentration of FFAs derived from the hydrolysis of TAG. Because FFAs elicit 
liponecrosis, it is likely that PE21 delays yeast chronological aging by delaying the onset 
of age-related liponecrosis.  
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 The 10 analyzed lipid classes of these 4 mutants are tabulated in both Sections 
3.4 (without PE21) and 3.5 (with PE21). As mentioned earlier, the focus of this study was 
on 4 mutant strains which have impaired enzymes responsible for the lipolytic breakdown 
of TAG in lipid droplets. The results described in Section 3.4 (without PE21; Figures 14, 
16, 15 and 20) show that the concentration of TAG is higher in all 4 mutant strains in 
comparison with wild-type strain, whereas the concentration of FFAs is lower in 
comparison with wild-type strain. Similar findings are reported in Section 3.5 (with PE21; 
Figures 22, 24, 26 and 28). Indeed, TAG concentration in cells of each of the 4 mutants 
is higher in comparison wild-type strain, while the concentration of FFAs is lower in 
comparison with wild-type strain. The values shown in these figures represent the mean 
of two replicates and the n value for standard deviation is 2. In sum, these findings support 
the notion that each of the 4 mutant strains has a low rate of TAG lipolysis in lipid droplets.  
 Future studies should focus on the investigation of mechanisms underlying the 
essential role of lipid metabolism in yeast chronological aging delay by PE21. Specifically, 
it would need to be tested how the deletions of genes encoding enzymes involved in 
different aspects of lipid metabolism influence the concentration of different lipid classes 
and how these mutations impact CLS of yeast culture with or without PE21.  
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Discussion of the thesis 
 In this thesis, an optimized LC-MS/MS method has been developed. This method 
was successfully used to identify and quantify 10 different lipid classes of Saccharomyces 
cerevisiae. Prior to analysis of lipid sample by mass spectrometer, it was important to 
isolate and purify lipid species from other components of yeast cells which are the major 
source of matrix effect and isobaric peaks in mass spectrometry.  
 Currently, there are 3 most widely used methods of lipid extraction. Herein, all 3 
methods were tested and compared to find the most efficient extraction method for S. 
cerevisiae lipid classes. The results of all 3 extraction methods in section 2.0 suggest that 
the most efficient extraction method for all 10 lipid classes is still the gold-standard method 
that uses a mixture of chloroform and methanol for extraction.  
 The ionization efficiencies of most frequently used mobile phase additives are 
tested and compared in section 2.0. To minimize an error in assessing these efficiencies 
by each of the 3 methods, the LC-MS/MS parameters, mobile phases and re-solubilizing 
solvent were kept constant. The results presented in section 2.0 show that the most 
efficient ionization additives are ammonium formate in the positive mode and ammonium 
acetate in the negative mode. It has been reported in literature that the addition of minute 
concentrations of organic acids, such as formic acid and acetic acid, enhances the 
ionization of lipids by decreasing the matrix effects through lowering of pH in the sample. 
Nevertheless, our results show the above-mentioned organic salts without any acids give 
the optimal ionization for each of the 10 lipid classes analyzed.  
 Even though almost all published studies used the same mobile phases A and B 
containing the same additives for both positive and negative modes of ionization, our 
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results suggest that different organic salts must be added to obtain an optimal ionization 
efficiency for each of the ionization modes (Table 5).  
 Using the optimized lipid extraction and LC-MS/MS methods developed in this 
thesis, the effects of the willow bark extract (which is called PE21) on the lipidome of 
Saccharomyces cerevisiae was analyzed. The results in section 2.3 show that PE21 
considerably remodels the lipid composition of the wild-type strain of Saccharomyces 
cerevisiae. Although PE21 alters the concentration of all 10-analyzed lipid classes, our 
focus of study was on FFA and its storage form triacylglycerol.  
 In section 3.0, the lipid profiles of 11 mutant strains were analyzed and compared 
to that of wild-type strain using cells cultured without and with PE21. The mutant strains 
studied are impaired in different pathways of lipid metabolism in various organelles of 
Saccharomyces cerevisiae. The purpose of this part of the study was to determine or 
narrow down the possible mechanism through which PE21 increases the CLS of 
Saccharomyces cerevisiae.  
 The result in section 3.0 shows that PE21 remodels the lipidome of all mutant 
strains, as compared to the corresponding mutant strains when the cells were cultured 
without PE21. The results for all mutant strains were compared with wild-type strain in the 
presence or absence of PE21; these data are tabulated in supplementary section. The 
results for 4 mutant strains impaired in FFA metabolism were studied more in detail, as 
described in section 3.0.  
 It has been hypothesized in Dr. Vladimir Titorenko’s lab that one of the possible 
mechanisms through which PE21 increases the CLS of Saccharomyces cerevisiae is by 
decreasing the rate of liponecrosis. A detailed description of liponecrosis is  provided in 
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section 3.0. The findings support this hypothesis for all 4 mutant strains. First, the 
concentrations of both TAG and FFA were analyzed in all mutant strains and compared 
to wild-type strain, using cells cultured with and without PE21. The data of these 
experiments confirm that in all 4 mutant strains the concentration of TAG is increased and 
the concentration of FFA is decreased as compared to wild-type strain. Moreover, the 
CLSs of mutant strains having lower FFA concentrations were compared to that of wild-
type strain. These experiments have revealed that the CLSs of all these mutant strains 
are higher than that of wild-type strain.  
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